# جمعية أطباء القلب الاردنية > لخدمة أطباء القلب بالمملكة والوطن العربي ## Posts - [Center of Excellence Criteria For  Transcatheter Tricuspid Valve Interventions (TTVI )— Key Points (2026)](https://jordan-cardiac.org/en/center-of-excellence-criteria-for-transcatheter-tricuspid-valve-interventions-ttvi-key-points-2026/): Center of Excellence Criteria For Transcatheter Tricuspid Valve Interventions (TTVI )— Key Points (2026) • New multi-society consensus (ACC/AHA + others) • Severe TR + symptomatic despite GDMT • TEER / TTVR → QoL benefit only (no mortality benefit) • Major challenges: • Patient selection • Timing • Limited long-term data • Mandatory Heart Team (multidisciplinary) • Center requirements (high volume): • Surgery, TAVI, TEER, TEE volumes • Full structural + EP support • Operator requirements: • Structural experience (≥50 cases) • Device-specific training • Procedure: • TEER: ≥2 operators • TTVR: multidisciplinary (3 operators) • Program maintenance: • Ongoing […] - [Global Blood Pressure Targets and Treatment Thresholds Across Major Guidelines (2025 Update)](https://jordan-cardiac.org/en/global-blood-pressure-targets-and-treatment-thresholds-across-major-guidelines-2025-update/): Global Blood Pressure Targets and Treatment Thresholds Across Major Guidelines (2025 Update) AHA/ACC 2025 (USA) • Start treatment at ≥130/80 mm Hg • Target: • <130/80 mm Hg for most • Encourage <120 SBP (if tolerated, especially high-risk) • Reflects shift toward intensive BP control ESC 2024 / ESH 2023 (Europe) • Classification: • 130–139 / 85–89 → “high-normal” • Treatment: • Pharmacotherapy mainly for high-risk patients • Targets: • Generally <130/80 mm Hg • ❗ Avoid aggressive lowering: • Do NOT target <120 SBP or <70 DBP ISH 2020 (Global) • Initial goal: • Reduce BP by ≥20/10 mm […] - [New-generation Guide  extension  catheter (CrossFAST)](https://jordan-cardiac.org/en/new-generation-guide-extension-catheter-crossfast/): New-generation Guide  extension  catheter (CrossFAST) Takeaway : • Delivers devices when conventional tools fail • Effective in calcified, tortuous, uncrossable lesions • Safer deep intubation → ↓ dissection risk • No balloon support → faster PCI • May avoid atherectomy 🎯 Bottom line: Simpler, safer, faster complex PCI Source: JSCAI, 2026 https://www.sciencedirect.com/science/article/pii/S2772930326000050 - [LDL <55 vs <70 mg/dL (Ez-PAVE): Lower is Better](https://jordan-cardiac.org/en/ldl/): LDL <55 vs <70 mg/dL (Ez-PAVE): Lower is Better • LDL <55 mg/dL → ↓ events 33% (3 years) • ↓ MI + ↓ revascularization  More intensive LDL lowering = better outcomes Source • TCTMD — ACC 2026 Conference Coverage • NEJM (simultaneous publication)  Link (direct): https://www.tctmd.com/news/very-low-ldl-levels-best-secondary-prevention-ez-pave Practice Implication • Target: LDL <55 mg/dL in ASCVD • Strategy: • Statin → + Ezetimibe → ± PCSK9 •  Start early, treat aggressively - [Impella + PCI vs PCI Alone (STEMI-DTU): No Benefit… More Harm](https://jordan-cardiac.org/en/impella-pci-vs-pci-alone-stemi-dtu-no-benefit-more-harm/): Impella + PCI vs PCI Alone (STEMI-DTU): No Benefit… More Harm • No reduction in infarct size •  ↑ major bleeding & vascular complications (~6×) • No improvement in clinical outcomes • Population: Anterior STEMI without shock  Routine use not recommended Source • TCTMD — ACC 2026 Conference Coverage • JACC (simultaneous publication)  Link (direct): https://www.tctmd.com/news/mechanical-circulatory-support-doesnt-reduce-infarct-size-stemi - [Practice-Changing Interventional Cardiology — ACC.26 (Bullet Summary)](https://jordan-cardiac.org/en/practice-changing-interventional-cardiology-acc-26-bullet-summary/): Practice-Changing Interventional Cardiology — ACC.26 (Bullet Summary) • CHIP-BCIS3 (Impella in high-risk PCI): → No benefit in 1-year outcomes → ↑ vascular complications + possible ↑ CV death  Routine LV unloading not supported • ALL-RISE (FFRangio – AI angiography-based FFR): → Noninferior to wire-based FFR (MACE ~6.9% vs 7.1%) → ↓ procedure & fluoroscopy time  Simpler, wire-free physiology • FAST-III (vFFR): → Noninferior to wire-based FFR (MACE identical ~7.5%) → ↓ contrast, radiation, procedure time  Angio-derived physiology validated • ORBITA-CTO (Sham-controlled CTO PCI): → ↓ angina + ↑ quality of life → No hard events (small study)  True symptomatic benefit […] - [Angio-Derived FFR -ACC 2026](https://jordan-cardiac.org/en/angio-derived-ffr-acc-2026/): Angio-Derived FFR -ACC 2026 • Software-based FFR from angiography images (no pressure wire)  Trials • ALL-RISE (FFRangio) • FAST III (vFFR)  Key Result • Noninferior to wire-based FFR  Clinical Outcomes (1 year) • Death / MI / Revascularization  No significant difference  Bottom Line  Wire-free physiology with similar outcomes https://cardiovascularbusiness.com/topics/clinical/interventional-cardiology/practice-changing-interventional-cardiology-research-grabs-acc26-spotlight - [ACC 2026 Scientific sessions, March 29, 2026)](https://jordan-cardiac.org/en/acc-2026-scientific-sessions-march-29-2026/): ACC 2026 Scientific sessions, March 29, 2026) SPIRIT-HF: No Clear Benefit of Spironolactone in HFpEF/HFmrEF • CV death + HF hospitalization  No difference vs placebo  But… • Trial underpowered (~50% enrollment) • High discontinuation https://www.tctmd.com/news/spironolactone-benefit-still-uncertain-hfpef-hfmrEF - [Catheter-Directed Therapy vs Anticoagulation in Intermediate-Risk PE (HI-PEITHO):](https://jordan-cardiac.org/en/catheter-directed-therapy-vs-anticoagulation-in-intermediate-risk-pe-hi-peitho/): Catheter-Directed Therapy vs Anticoagulation in Intermediate-Risk PE (HI-PEITHO): Early Benefit… in Selected Patients (Follow-up: 7 days) • ↓ Primary events 61%(No ↑ major bleeding. No mortality difference  Only in carefully selected patients) Selection Basis: • RV dysfunction (RV/LV ≥ 1.0) • ↑ Troponin • ≥2 signs of cardiorespiratory stress  Closest to Category D (pre-shock) Source • TCTMD — ACC 2026 Conference Coverage • NEJM (simultaneous publication)  Link (direct): https://www.tctmd.com/news/hi-peitho-catheter-directed-therapy-bests-anticoagulation-intermediate-risk-pe - [LAAO (Watchman) vs DOAC (CHAMPION-AF):](https://jordan-cardiac.org/en/laao-watchman-vs-doac-champion-af/): LAAO (Watchman) vs DOAC (CHAMPION-AF): Alternative… Not Replacement (Follow-up: 3 years) • Non-inferior, not superior • Source • TCTMD — ACC 2026 Conference Coverage • NEJM (simultaneous publication) Link (direct): https://www.tctmd.com/news/champion-af-win-watchman-flx-caveats Practice Implication • Use in: • Patients unsuitable for anticoagulation - [New Ideas in Cardiology — March 2026 (ACC Conference Coverage Highlights)](https://jordan-cardiac.org/en/new-ideas-in-cardiology-march-2026-acc-conference-coverage-highlights/): 🫀 New Ideas in Cardiology — March 2026 (ACC Conference Coverage Highlights) 📌 Source: TCTMD (ACC 2026 coverage) 1-Mitral Hemivalve (Polaris) 👉 Replace only the posterior leaflet → Preserve the native anterior leaflet → Less complex than full valve replacement → Designed to reduce LVOT obstruction and improve physiology 2-Echo = The Eyes of The Structural Procedure 👉 Essential for guiding modern structural interventions → Provides real-time visualization inside the heart 👉 Interventional Echo specialists exposed to higher radiation (~×12) 👉 New ceiling-suspended suit (Zero-Gravity) → Achieves near-zero radiation exposure 3-LAVA-ECMO 👉 Drains blood directly from the left atrium (transseptal) […] - [(2026 Hypertension Study)](https://jordan-cardiac.org/en/2026-hypertension-study/): (2026 Hypertension Study) • Frailty > age for BP targeting Best SBP Targets • Frail patients: → 120–140 mmHg (Best and safer range) • Non-frail patients: → 110–120 mmHg (tighter control) • 110–120 mmHg: best → ↓ MACE • <110 mmHg: uncertain benefit • ≥130 mmHg: ↑ risk → avoid Sweet spot = 110–120 mmHg (non-frail) Bottom Line Personalize BP by frailty, not age One target does NOT fit all https://www.medscape.com/…/frailty-index-may-guide… - [Transcatheter Aortic Regurgitation – Trilogy Valve in the FDA - Pre-Approval Stage](https://jordan-cardiac.org/en/transcatheter-aortic-regurgitation-trilogy-valve-in-the-fda-pre-approval-stage/): Transcatheter Aortic Regurgitation – Trilogy Valve in the FDA – Pre-Approval Stage Source: Medical News Update – TCTMD (2026) Clinical Problem • Transcatheter valves (TAVR) were historically designed for aortic stenosis (AS) • These systems rely on annular and leaflet calcification for: • Anchoring • Stability • In aortic regurgitation (AR): • Often no calcification • → Traditional TAVR valves fail to anchor properly • → High risk of: • Valve migration • Paravalvular leak Why AR Was Challenging • Lack of calcified landing zone • Dilated annulus and root • Unpredictable fixation with standard devices 👉 → AR long […] - [Vaccination for Healthy Aging (Medscape, 2026)](https://jordan-cardiac.org/en/vaccination-for-healthy-aging-medscape-2026/): Vaccination for Healthy Aging (Medscape, 2026) Concept & Rationale • “Immunofitness” = maintaining a well-regulated immune system with aging • Targets immunosenescence (decline in immune function) and inflammaging (chronic low-grade inflammation) • Vaccination acts as a functional support tool, not an anti-aging cure Mechanisms • May induce trained immunity → broader protection beyond target pathogen Key Vaccines for Immunofitness • Strongest impact: • Influenza • RSV • Pneumococcal • COVID-19 • Herpes zoster • Others (e.g., tetanus, HPV, hepatitis B): important but impact depends on individual risk Clinical Benefits Beyond Infection Prevention • ↓ Cardiovascular events (MI, CV mortality) — […] - [When to Use Lp(a) & CAC in 1° Prevention: When Risk Is Unclear (Gray Zone)](https://jordan-cardiac.org/en/when-to-use-lpa-cac-in-1-prevention-when-risk-is-unclear-gray-zone-2/): When to Use Lp(a) & CAC in 1° Prevention: When Risk Is Unclear (Gray Zone) Source: TCTMD Date: March 19, 2026 Link: https://www.tctmd.com/news/lpa-and-cac-levels-independently-predict-long-term-ascvd-risk When to Use CAC • Primary prevention • Intermediate or uncertain risk (gray zone) • Elevated Lp(a) with unclear treatment decision Key Findings (JACC, 2026) • Lp(a) and CAC independently predict 15-year ASCVD risk • Highest risk: • Lp(a) >50 mg/dL + CAC >0 → HR ~3.0 Important Insight • CAC = 0 → low absolute risk, even with high Lp(a); risk is slightly higher than with low Lp(a), but remains overall low. Risk Interpretation • Lp(a) […] - [Ultraprocessed Foods Raise Heart Risk (2026)](https://jordan-cardiac.org/en/ultraprocessed-foods-raise-heart-risk-2026/): Ultraprocessed Foods Raise Heart Risk (2026) Source: TCTMD Date: March 17, 2026 Link: https://www.tctmd.com/news/ultraprocessed-food-again-linked-higher-cvd-risk-mesa Key Findings • Higher intake → ↑ CVD risk (+5% per serving) Dose–Response • High intake → ~66% higher risk Mechanisms • ↑ Refined sugars, sodium, unhealthy fats • ↓ Fiber, micronutrients • ↑ Inflammation, microbiome disruption • → Overeating Clinical Implications • Ultraprocessed food = modifiable CV risk factor • Diet assessment should be routine and detailed 🎯 Bottom Line • Food quality matters—not just calories • Reducing ultraprocessed intake = practical CV prevention - [When to Use Lp(a) & CAC in 1° Prevention: When Risk Is Unclear (Gray Zone)](https://jordan-cardiac.org/en/when-to-use-lpa-cac-in-1-prevention-when-risk-is-unclear-gray-zone/): When to Use Lp(a) & CAC in 1° Prevention: When Risk Is Unclear (Gray Zone) Source: TCTMD Date: March 19, 2026 When to Use CAC • Primary prevention • Intermediate or uncertain risk (gray zone) • Elevated Lp(a) with unclear treatment decision Key Findings (JACC, 2026) • Lp(a) and CAC independently predict 15-year ASCVD risk • Highest risk: • Lp(a) >50 mg/dL + CAC >0 → HR ~3.0 Important Insight • CAC = 0 → low absolute risk, even with high Lp(a); risk is slightly higher than with low Lp(a), but remains overall low. Risk Interpretation • Lp(a) done once […] - [Recommended Echo Follow-Up Intervals in Aortic Stenosis](https://jordan-cardiac.org/en/recommended-echo-follow-up-intervals-in-aortic-stenosis/): Recommended Echo Follow-Up Intervals in Aortic Stenosis Source: Circulation-TCTMD MARCH 18, 2026 Takeaways: • In >20,000 AS patients, guideline-based echo follow-up ↓ mortality and ↑ timely AVR • Biggest gap: severe AS under-followed (~50%) Recommended Echo Follow-Up: • Mild AS: every 3–5 years • Moderate AS: every 1–2 years • Severe AS: every 6–12 months Key point: Follow-up interval depends on disease severity — not symptoms alone. https://www.tctmd.com/news/echocardiographic-surveillance-doesnt-measure-guidelines   - [Prompt Antithrombotic Treatment After GI Bleeds Benefits CVD](https://jordan-cardiac.org/en/prompt-antithrombotic-treatment-after-gi-bleeds-benefits-cvd-2/): Prompt Antithrombotic Treatment After GI Bleeds Benefits CVD Patients Source: Medscape Medical News – Mar 13, 2026 Key points – Most patients receiving antiplatelets or anticoagulants. Main Findings Effect of Restarting Antithrombotic Therapy •⁠ ⁠Resuming therapy within 4–7 days after bleeding: •⁠ ⁠Importantly: – Early resumption did NOT increase recurrent GIB risk. •⁠ ⁠Once hemostasis is achieved, clinicians should: – Develop a clear plan to restart antithrombotics https://www.medscape.com/viewarticle/prompt-antithrombotic-treatment-after-gi-bleeds-benefits-cvd-2026a10007sd - [Egg Consumption and Cardiovascular Health – Key Points](https://jordan-cardiac.org/en/egg-consumption-and-cardiovascular-health-key-points/): Egg Consumption and Cardiovascular Health – Key Points Source: Medscape medical News, 9March 2026-Journal of Poultry Science, 2026 •⁠ ⁠Eggs are nutrient-rich, providing lutein and zeaxanthin with antioxidant benefits. •⁠ ⁠Egg intake may raise serum cholesterol slightly, but shows little or no increase in cardiovascular disease risk. •⁠ ⁠Studies suggest 1 egg/day can increase HDL and reduce oxidized LDL. •⁠ ⁠Moderate intake (3–4 eggs/week) was associated with lower multivessel CAD prevalence in some studies. •⁠ ⁠Overall evidence supports moderate egg consumption as part of a healthy diet. Link: https://www.jstage.jst.go.jp/article/jpsa/63/0/63_2026001/_pdf?utm_source=chatgpt.com - [Long-Term Glycemic Control in Type 2 Diabetes – Key Points](https://jordan-cardiac.org/en/long-term-glycemic-control-in-type-2-diabetes-key-points/): Long-Term Glycemic Control in Type 2 Diabetes – Key Points Source : Medscape 9 March, 2026 •⁠ ⁠The most accurate statement: Glycemic control reduces the risk of diabetes-related microvascular complications (chosen by 81% of respondents). •⁠ ⁠Elevated blood glucose is strongly associated with microvascular complications such as retinopathy, nephropathy, and neuropathy. •⁠ ⁠According to the American Diabetes Association (ADA), improving long-term glycemic control lowers the risk of these complications. •⁠ ⁠Glycemic management does not replace cardiovascular risk management; diabetes care must also address lipids, blood pressure, and lifestyle factors. •⁠ ⁠ADA guidance suggests optimizing glycemic management when triglycerides ≥150 mg/dL […] - [New Large-Bore Stroke Catheter Cleared by FDA](https://jordan-cardiac.org/en/new-large-bore-stroke-catheter-cleared-by-fda/): New Large-Bore Stroke Catheter Cleared by FDA Source: NeuroNews International, March 12, 2026 Key Points: •⁠ ⁠The Toro 88 Superbore Catheter (Toro Neurovascular) Catheter has received FDA clearance for use in complex stroke interventions. •⁠ ⁠The device is a large-bore catheter designed to improve support, stability, and trackability during time-sensitive neurovascular procedures. •⁠ ⁠The first clinical use in the United States was performed by Dr. Satoshi Tateshima (UCLA). •⁠ ⁠Early experience suggests strong navigation and procedural control, which may be valuable in challenging stroke cases. Toro Neurovascular gains US FDA clearance for Toro 88 super-bore catheter - [Prompt Antithrombotic Treatment After GI Bleeds Benefits CVD](https://jordan-cardiac.org/en/prompt-antithrombotic-treatment-after-gi-bleeds-benefits-cvd/): Prompt Antithrombotic Treatment After GI Bleeds Benefits CVD Patients Source: Medscape Medical News – Mar 13, 2026 Key points – Most patients receiving antiplatelets or anticoagulants. Main Findings Effect of Restarting Antithrombotic Therapy •⁠ ⁠Resuming therapy within 4–7 days after bleeding: •⁠ ⁠Importantly: – Early resumption did NOT increase recurrent GIB risk. •⁠ ⁠Once hemostasis is achieved, clinicians should: – Develop a clear plan to restart antithrombotics •⁠ ⁠https://www.medscape.com/viewarticle/prompt-antithrombotic-treatment-after-gi-bleeds-benefits-cvd-2026a10007sd - [CrossFAST: The Next-Generation Guide Extension Catheter in Complex PCI](https://jordan-cardiac.org/en/crossfast-the-next-generation-guide-extension-catheter-in-complex-pci/): CrossFAST: The Next-Generation Guide Extension Catheter in Complex PCI Source: Medical News – March 10, 2026 Original Study: JSCAI, February 2026 •⁠ ⁠The device uses a microcatheter-led delivery system designed to enable safe deep coronary intubation during complex PCI procedures. •⁠ ⁠It has been successfully used in cases where conventional guide extension catheters failed to cross difficult lesions. •⁠ ⁠CrossFAST enabled successful stent delivery through calcified and tortuous coronary segments. •⁠ ⁠The design improves pushability and smooth transition, allowing the catheter to advance without balloon-assisted tracking. •⁠ ⁠It may also reduce the risk of coronary dissection compared with earlier blunt-tip […] - [Multisociety Jordan National Dyslipidemia Management Clinical Protocols Initiative](https://jordan-cardiac.org/en/multisociety-jordan-national-dyslipidemia-management-clinical-protocols-initiative/): Multisociety Jordan National Dyslipidemia Management Clinical Protocols Initiative A Collaborative Program of Nine Jordanian Medical Societies Coordinated by the Jordan Cardiac Society (JCS) ⸻ Participating Societies •⁠ ⁠Jordanian Cardiac Society (JCS) •⁠ ⁠Jordan Atherosclerosis Society (JAS) •⁠ ⁠Jordan Society of General Practitioners (JSGP) •⁠ ⁠Jordan Society of Internal Medicine (JSIM) •⁠ ⁠Jordan Society of Nephrology (JSN) •⁠ ⁠Jordan Society of Family Medicine (JSFM) •⁠ ⁠Jordan Emergency Medicine Society (JEMS) •⁠ ⁠Jordan Endocrine and Diabetes Society (JEDS) •⁠ ⁠Jordan Nutrition Society (JNS) Core Principle Understanding ApoB in Clinical Practice Cholesterol and triglycerides are fatty substances that do not dissolve in the […] - [Multisociety Jordan National Hypertension Registry (JNHR) Initiative-Entry Form](https://jordan-cardiac.org/en/multisociety-jordan-national-hypertension-registry-jnhr-initiative-entry-form/): Multisociety Jordan National Hypertension Registry (JNHR) Initiative-Entry Form A Collaborative Program of Nine Jordanian Medical Societies Coordinated by the Jordanian Cardiac Society (JCS) Participating Societies •⁠ ⁠Jordanian Cardiac Society (JCS) •⁠ ⁠Jordan Atherosclerosis Society (JAS) •⁠ ⁠Jordan Society of General Practitioners (JSGP) •⁠ ⁠Jordan Society of Internal Medicine (JSIM) •⁠ ⁠Jordan Society of Nephrology (JSN) •⁠ ⁠Jordan Society of Family Medicine (JSFM) •⁠ ⁠Jordan Emergency Medicine Society (JEMS) •⁠ ⁠Jordan Endocrine and Diabetes Society (JEDS) •⁠ ⁠Jordan Nutrition Society (JNS) Jordan National Hypertension Registry – Primary Care Entry Form (This form can be filled in 2 minutes) Section A – […] - [Multisociety Jordan National Hypertension Registry (JNHR) Initiative](https://jordan-cardiac.org/en/multisociety-jordan-national-hypertension-registry-jnhr-initiative/): Multisociety Jordan National Hypertension Registry (JNHR) Initiative National Implementation Plan and Operational Framework A Collaborative Program of Nine Jordanian Medical Societies Coordinated by the Jordanian Cardiac Society (JCS) Participating Societies •⁠ ⁠Jordanian Cardiac Society (JCS) •⁠ ⁠Jordan Atherosclerosis Society (JAS) •⁠ ⁠Jordan Society of General Practitioners (JSGP) •⁠ ⁠Jordan Society of Internal Medicine (JSIM) •⁠ ⁠Jordan Society of Nephrology (JSN) •⁠ ⁠Jordan Society of Family Medicine (JSFM) •⁠ ⁠Jordan Emergency Medicine Society (JEMS) •⁠ ⁠Jordan Endocrine and Diabetes Society (JEDS) •⁠ ⁠Jordan Nutrition Society (JNS) Registry Completion Model The registry is designed to minimize physician workload and maximize feasibility in […] - [Multisociety Jordan National Hypertension Clinical Protocols Initiative](https://jordan-cardiac.org/en/multisociety-jordan-national-hypertension-clinical-protocols-initiative/): Multisociety Jordan National Hypertension Clinical Protocols Initiative A Collaborative Program of Nine Jordanian Medical Societies Coordinated by the Jordan Cardiac Society (JCS) Participating Societies: Jordan Cardiac Society (JCS) Jordan Atherosclerosis Society (JAS) Jordan Society of General Practitioners (JSGP) Jordan Society of Internal Medicine (JSIM) Jordan Society of Nephrology (JSN) Jordan Society of Family Medicine (JSFM) Jordan Emergency Medicine Society (JEMS) Jordan Endocrine and Diabetes Society (JEDS) Jordan Nutrition Society (JNS) Based on: ESH/ESC 2024 ACC/AHA 2025 and CCS Updates,  and International Society of Hypertension 2020 Preface : Each population requires its most suitable guideline, and the best blood pressure categorization […] - [Developing Advanced Emergency Units in Remote Areas (in Jordan)– Concept Inspired by Freestanding EDs (USA)](https://jordan-cardiac.org/en/developing-advanced-emergency-units-in-remote-areas-in-jordan-concept-inspired-by-freestanding-eds-usa/): Developing Advanced Emergency Units in Remote Areas (in Jordan)– Concept Inspired by Freestanding EDs (USA) Key notes : •⁠ ⁠Freestanding Emergency Departments (Freestanding EDs) are independent 24/7 emergency facilities located outside hospitals, yet equipped with hospital-level diagnostic capabilities. •⁠ ⁠Developed in the United States to address ED overcrowding, improve access in remote areas, and accelerate diagnosis of time-critical emergencies such as chest pain and stroke. •⁠ ⁠This model is rapidly expanding in the U.S., representing ~11% of all emergency departments nationwide. Core Structure and Diagnostic Capabilities •⁠ ⁠Designed to manage 80–90% of common emergency presentations, while severe cases are transferred […] - [Rapid hs-Troponin Protocol in EDs —](https://jordan-cardiac.org/en/rapid-hs-troponin-protocol-in-eds/): Rapid hs-Troponin Protocol in EDs — Key points : •⁠ ⁠>32,500 patients with chest pain included in the RACE-IT study. •⁠ ⁠Patients evaluated in: – 5 hospital EDs – 4 freestanding EDs: (Freestanding ED: a fully equipped 24/7 emergency department located outside a hospital, providing rapid diagnosis and stabilization, with transfer to hospitals if admission is needed.) •⁠ ⁠hs-troponin protocols allow MI rule-out in ~1 hour, faster than traditional multi-hour testing. •⁠ ⁠Safe discharge rates – Hospital EDs: 50–54% – Freestanding EDs: 86–95% •⁠ ⁠Freestanding EDs achieved higher safe discharge rates for low-risk chest pain patients with similar safety outcomes. […] - [Drug-Eluting Balloons vs Stents in STEMI – Key Points](https://jordan-cardiac.org/en/drug-eluting-balloons-vs-stents-in-stemi-key-points/): Drug-Eluting Balloons vs Stents in STEMI – Key Points •⁠ ⁠Debate in interventional cardiology: drug-eluting balloons (DEB) vs drug-eluting stents (DES) for de novo coronary lesions. •⁠ ⁠DES remain the current standard in STEMI primary PCI. •⁠ ⁠Potential advantages of DEB: – No metal left in the artery – Lower thrombosis risk – May reduce need for prolonged dual antiplatelet therapy – Vessel remains “clean” if restenosis occurs. •⁠ ⁠Limitations of balloon therapy: – Risk of vessel dissection, which may still require stent implantation. •⁠ ⁠Restenosis rates with modern DES are low (<5%), which explains their continued dominance. •⁠ ⁠COPERNICAN […] - [Epinephrine in Cardiac Arrest – Simplified Key Message](https://jordan-cardiac.org/en/epinephrine-in-cardiac-arrest-simplified-key-message/): Epinephrine in Cardiac Arrest – Simplified Key Message   •⁠ ⁠Epinephrine can restart the heart’s circulation during cardiac arrest, but some survivors may have serious brain injury afterward. •⁠ ⁠Current guidelines (European Resuscitation Council 2025) still recommend 1 mg epinephrine every 3–5 minutes during advanced life support. •⁠ ⁠This has led to an ongoing debate: is improving short-term survival worth the risk of severe neurological disability in some survivors? Source: Medscape Medical News – Feb 27, 2026 https://www.medscape.com - [The Art of the Quadpill: A New Strategy for Blood Pressure Control](https://jordan-cardiac.org/en/the-art-of-the-quadpill-a-new-strategy-for-blood-pressure-control/): The Art of the Quadpill: A New Strategy for Blood Pressure Control Key Points: •⁠ ⁠Hypertension management is shifting toward early multidrug therapy and single-pill strategies to improve BP control and adherence. •⁠ ⁠Triple single-pill therapy (telmisartan + amlodipine + indapamide) showed 70% BP control vs 37% with placebo in a phase 3 trial. (Note: Amlodipine may cause lower limb edema, dose-related; combining with ACE inhibitors or ARBs can reduce edema by ~38%, along with leg elevation or compression stockings.) •⁠ ⁠Quadpill strategy (ultra-low quarter1/4-recommended dose combination of four antihypertensive drugs) showed greater BP reduction than standard monotherapy in the […] - [Worldwide Variation in Radiation Doses in Medical Imaging](https://jordan-cardiac.org/en/worldwide-variation-in-radiation-doses-in-medical-imaging/): Worldwide Variation in Radiation Doses in Medical Imaging JAMA | February 2026 A Call for Standardization of Optimal Radiation Protocols in Cath Labs and Cardiac Imaging Study Overview: • Included 19,302 patients • From 101 countries • Evaluated radiation doses in common cardiac imaging tests • Published in JAMA – February 2026 Key Findings • Significant global variation in radiation doses for the same imaging tests • Western Europe had the lowest average doses • Africa showed the highest doses, particularly for CCTA • In lower-income countries, CCTA doses were up to 280% higher than high-income countries.      •  […] - [Questions ... cases](https://jordan-cardiac.org/en/questions-cases/): Question 1 Case A 64-year-old man with COPD and poorly controlled type 2 diabetes presents with progressive decline in lung function. Which mechanism best explains how diabetes worsens COPD? A) Bronchial smooth muscle AGE binding B) Insulin resistance causing bronchospasm C) Thick airway mucus from hyperglycemia D) Hyperglycemia-induced oxidative stress Answer: D) Hyperglycemia-induced oxidative stress Explanation (Very Short) Hyperglycemia increases oxidative stress, leading to lung tissue damage and impaired repair. Clinical Pearl Poor glycemic control accelerates COPD progression. Question 2 Case A 70-year-old COPD patient presents with acute dyspnea and wheezing. Treatment for COPD exacerbation gives minimal improvement. Which condition […] - [Question: Which bariatric surgery technique has the best effect for sustained reductions in systolic and diastolic blood pressure?](https://jordan-cardiac.org/en/question-which-bariatric-surgery-technique-has-the-best-effect-for-sustained-reductions-in-systolic-and-diastolic-blood-pressure/): Question Which bariatric surgery technique has the best effect for sustained reductions in systolic and diastolic blood pressure? A. Gastric banding B. Biliopancreatic diversion with duodenal switch (BPD/DS) C. Roux-en-Y gastric bypass D. Duodenal-jejunal bypass liner (DJBL) Answer A recent review evaluating the impact of metabolic surgery on hypertension found that Roux-en-Y gastric bypass, the most commonly performed bariatric procedure, had the most significant and sustained effect on reducing both systolic and diastolic blood pressure. Although other techniques, such as gastric banding, BPD/DS, and DJBL, demonstrated effectiveness compared with nonsurgical management, the differences were not statistically significant. This finding is […] - [Question: What is the most effective nonpharmacologic intervention for lowering blood pressure?](https://jordan-cardiac.org/en/question-what-is-the-most-effective-nonpharmacologic-intervention-for-lowering-blood-pressure/): Question What is the most effective nonpharmacologic intervention for lowering blood pressure? A. Salt restriction B. Aerobic exercise C. Isometric training D. Dietary Approaches to Stop Hypertension (DASH) diet Answer: While salt restriction, aerobic exercise, and isometric training all lower blood pressure, the DASH diet has the strongest and most consistent evidence for overall BP reduction. So the correct answer is : D. Dietary Approaches to Stop Hypertension (DASH) diet - [Amiodarone Drug Interactions in Heart Failure – Key Points](https://jordan-cardiac.org/en/amiodarone-drug-interactions-in-heart-failure-key-points/): Amiodarone Drug Interactions in Heart Failure – Key Points 1️⃣ Negative Chronotropes & Conduction-Slowing Agents Drugs involved: • β-blockers • Digoxin • Verapamil / Diltiazem (non-DHP CCBs) • Ivabradine • Clonidine 2️⃣ Other Antiarrhythmics & QT-Prolonging Agents Risk of combination: • QTc prolongation • Torsade de pointes (TdP) • Proarrhythmia (especially IV amiodarone) Clinical guidance: • Avoid combining with other QT-prolonging drugs unless absolutely necessary • Reserve dual therapy for life-threatening ventricular arrhythmias • Monitor QTc closely 3️⃣ Diuretics & Electrolyte-Disturbing Therapies Electrolyte abnormalities that increase risk: • Hypokalemia • Hypomagnesemia • Hypocalcemia Common contributing therapies: • Loop and thiazide […] - [Clinical Case Scenario – Obesity & Antihypertensive Choice](https://jordan-cardiac.org/en/clinical-case-scenario-obesity-antihypertensive-choice/): Clinical Case Scenario – Obesity & Antihypertensive Choice A 54-year-old man with BMI 34 kg/m² presents with newly diagnosed hypertension (150/94 mm Hg). He has prediabetes and is motivated to lose weight. He expresses concern about medications that might make weight loss more difficult. You are selecting first-line pharmacologic therapy. Which antihypertensive drug class includes agents known to promote weight gain? A) ACE inhibitors B) ARBs C) Beta blockers D) Calcium channel blockers Correct Answer: C) Beta blockers • Older beta-blockers (e.g., atenolol, metoprolol) may be associated with modest weight gain and less favorable metabolic effects. • Vasodilating beta-blockers (e.g., […] - [By approximately how much does systolic blood pressure decrease for every two points of BMI reduction?](https://jordan-cardiac.org/en/by-approximately-how-much-does-systolic-blood-pressure-decrease-for-every-two-points-of-bmi-reduction/): By approximately how much does systolic blood pressure decrease for every two points of BMI reduction? A-2 mm Hg B-6 mm Hg C-8 mm Hg D-10 mm Hg SUBMIT & PROCEED     Correct Answer is B : About 5–6 mm Hg systolic and 3 mm Hg diastolic. A mean BMI reduction of ~2.3 is associated with a ~5.8 mm Hg drop in SBP. 2️⃣ Dose–Response Relationship Q: How does weight gain affect the risk of developing hypertension? A: The risk of hypertension increases by approximately 20–30% for every 5% increase in body weight. - [AHA Key Updates - from the 2026 ASA Ischemic Stroke Guideline](https://jordan-cardiac.org/en/aha-key-updates-from-the-2026-asa-ischemic-stroke-guideline/): AHA Key Updates – from the 2026 ASA Ischemic Stroke Guideline “American Stroke Association (ASA), a division of the AHA Published in: Stroke (AHA Journal)” 🔹 Early Recognition clinical tool  in EMS or ER – FAST & BE-FAST • FAST: Face droop, Arm weakness, Speech difficulty, Time • BE-FAST adds: • Balance disturbance • Eye/visual symptoms • Used by community and EMS for early detection • BE-FAST improves detection of posterior circulation strokes • Early recognition triggers rapid stroke alert activation 🔹 Coordinated Systems of Care • Integration between EMS, stroke centers, telemedicine networks, and emergency departments • “Time is […] - [Screening for lipids :](https://jordan-cardiac.org/en/screening-for-lipids/): Screening for lipids:   ESC/EAS recommends lipid screening from age ≥5 years if there is a family history of premature ASCVD. Explanation: Risk-based screening is recommended from age ≥5 years in children with positive family history. Screening from age ≥2 years is recommended if severe (homozygous) FH is suspected. - [At what age should routine evaluation for hypertension start for children and adolescents with obesity?](https://jordan-cardiac.org/en/at-what-age-should-routine-evaluation-for-hypertension-start-for-children-and-adolescents-with-obesity/): At what age should routine evaluation for hypertension start for children and adolescents with obesity? Options: • 3 years • 7 years • 10 years • 13 years Pediatric Blood Pressure Screening Blood pressure screening begins at age 3 years for all children. •⁠  ⁠Without obesity: measure annually. •⁠  ⁠With obesity/overweight: measure at every healthcare visit. The difference is not the starting age, but the frequency of monitoring, as obesity increases early cardiovascular risk. - [Statins Beyond the Myths: Benefits Stand Strong, Risks Limited ](https://jordan-cardiac.org/en/statins-beyond-the-myths-benefits-stand-strong-risks-limited/): Statins Beyond the Myths: Benefits Stand Strong, Risks Limited Source: The Lancet • Date: February 2026 • Essence: Large meta-analysis (>123,000 patients) found no evidence for most currently listed statin side effects; confirmed risks are mainly mild elevated liver enzymes. •   The Lancet meta-analysis found no strong evidence that statins cause most of the common, non-specific muscle complaints frequently attributed to them in routine clinical practice. • While true statin-associated myopathy exists, many generalized muscle aches reported in everyday practice are not clearly caused by statins. •   Recommendation: Remove unsupported warnings from statin labels and retain only evidence-based risks (primarily […] - [FDA Approval Led to More Young Patients Receiving TAVR](https://jordan-cardiac.org/en/fda-approval-led-to-more-young-patients-receiving-tavr/): FDA Approval Led to More Young Patients Receiving TAVR Source JACC — February 11, 2026 • In 2019, the FDA approved TAVR for low-risk patients. • After this decision, more patients under 65 years began receiving TAVR. • Many of these patients were lower risk and might previously have undergone surgery (SAVR). • Short-term results were generally good. • However, the very youngest patients (<65) showed higher 1-year mortality after adjustment. • This may reflect more complex disease patterns or hidden risk factors — not necessarily a procedural issue. • Guidelines still recommend SAVR for patients under 65 years. • […] - [Death After PCI Remains Rare (0.5%) — AMI Most Common Cause](https://jordan-cardiac.org/en/death-after-pci-remains-rare-0-5-ami-most-common-cause/): Death After PCI Remains Rare (0.5%) — AMI Most Common Cause Source: The American Journal of Cardiology Published: February 2026 Key Findings (PROGRESS-COMPLICATIONS Registry, 2014–2024) • 22,000 PCI procedures analyzed at two high-volume U.S. centers. • Overall in-hospital mortality: 0.5% (115 patients). • 13% of deaths occurred during the procedure. • 8.7% occurred within the first 24 hours. • 78.3% occurred after the first 24 hours. Main Causes of Death • Acute Myocardial Infarction (AMI): 58.3% • Infection: 6.1% • Aortic dissection: 3.5% Patient Profile (Those Who Died) • Mean age: 72 years • 62.6% male • High burden of […] - [Nabil Saadeh Who Discovers PCSK9 Cholesterol Therapies](https://jordan-cardiac.org/en/nabil-saadeh-who-discovers-pcsk9-cholesterol-therapies/): Nabil Saadeh Who Discovers PCSK9 Cholesterol Therapies Source: Medscape Date: February 16, 2026 • Egyptian-Canadian biochemist based  • Discovered the PCSK9 enzyme in 2003. • 2025 recipient of the Great Arab Minds Award in Medicine. Difference of PCSK9 Inhibitors • PCSK9 monoclonal antibodies (alirocumab, evolocumab): block circulating PCSK9 protein. • Inclisiran: reduces PCSK9 synthesis at the mRNA level. They inhibit the same target (PCSK9), but through different mechanisms • PCSK9 reduces the number of LDL receptors in the liver. • Fewer LDL receptors → higher “bad” LDL cholesterol in the bloodstream. • Blocking PCSK9 lowers LDL by ~50%. • Combined […] - [Post-MI Beta-Blockers (2024–2026): The EF-Driven Guidance ](https://jordan-cardiac.org/en/post-mi-beta-blockers-2024-2026-the-ef-driven-guidance/): Post-MI Beta-Blockers (2024–2026): The EF-Driven Guidance • The role of long-term beta-blockers after MI now depends largely on left ventricular ejection fraction (EF). • EF ≥50% (Preserved): • Contemporary trials show no clear outcome benefit. • Routine long-term use not supported if no other indication. • EF 40–49% (Mildly Reduced): • Consistent signal of meaningful benefit (↓ death/MI/HF). • Likely the most favorable group in current practice. • EF <40% or clinical HF: • Strong indication. • Remain foundational, survival-improving therapy. • In women with preserved EF, data suggest possible harm signals, so greater caution is warranted. Clear Take-Home Message: […] - [Endovascular Treatment for Long Femoropopliteal Lesions – Meta-Analysis (2026)](https://jordan-cardiac.org/en/endovascular-treatment-for-long-femoropopliteal-lesions-meta-analysis-2026/): Endovascular Treatment for Long Femoropopliteal Lesions – Meta-Analysis (2026) • Terminology note: PCI refers specifically to coronary intervention; femoropopliteal procedures are classified as peripheral endovascular revascularization. • Surgical bypass remains the gold standard for long femoropopliteal lesions. • A large meta-analysis supports an expanding role for less invasive revascularization strategies. • Newer technologies (drug-eluting stents, covered stents, drug-coated balloons) are associated with improved outcomes. • Results have improved in recent years with better devices and greater operator experience. • Particularly relevant in patients at high surgical risk. Source & Date: Study published in JSCAI – 16 January 2026 https://www.jscai.org/article/S2772-9303(25)01604-7/fulltext#tbl2 - [2026 ACC/AHA Acute Pulmonary Embolism Guideline](https://jordan-cardiac.org/en/2026-acc-aha-acute-pulmonary-embolism-guideline/): 2026 ACC/AHA Acute Pulmonary Embolism Guideline Risk Stratification by Clinical Categories (A–E) Published Feb 19, 2026, JACC & Circulation ACC / AHA Acute PE Clinical Categories — Key Clinical Signs at Each Stage (Including Oxygen) A-Category A — Asymptomatic / Subclinical PE Clinical Signs: • Incidentally detected PE (often on CT) • No dyspnea • No chest pain • Normal blood pressure • Normal heart rate • No RV dysfunction • Normal cardiac biomarkers • Oxygenation: SpO₂ ≥ 95% on room air (no oxygen requirement) Management Signal: No hospitalization required Outpatient management appropriate B-Category B — Symptomatic / Low Clinical […] - [Quadpill at Quarter Dose – A New First-Line Strategy in Hypertension](https://jordan-cardiac.org/en/quadpill-at-quarter-dose-a-new-first-line-strategy-in-hypertension/): Quadpill at Quarter Dose – A New First-Line Strategy in Hypertension Medscape Cardiology, February 13, 2026 QUARTET Trial -Published in The Lancet • Ultra–low-dose quadpill (¼ standard dose each: irbesartan 37.5 mg, amlodipine 1.25 mg, indapamide 0.625 mg, bisoprolol 2.5 mg) initiated from day one in mild–moderate hypertension. • QUARTET trial showed superior BP reduction (~6–7 mmHg additional systolic lowering) versus standard-dose monotherapy, without increased serious adverse events. • Concept: early low-dose multidrug synergy may outperform stepwise escalation while maintaining tolerability https://www.medscape.com/s/viewarticle/quadpill-strategy-gains-ground-hypertension-2026a10004lv - [Artificial Intelligence in Cardiology Working Group.](https://jordan-cardiac.org/en/artificial-intelligence-in-cardiology-working-group/): The Board of the Jordanian Society of Cardiologists met this evening and approved the creation of a new working group within the society, named the Artificial Intelligence in Cardiology Working Group. The group’s goals are to advance the integration of AI technologies in cardiovascular practice, enhance clinical decision support, foster AI-driven research and innovation, and collaborate with international AI initiatives in cardiology. - [Oral PCSK9 Inhibitor Enlicitide Achieves LDL-C Reduction Comparable to Injectable Therapies](https://jordan-cardiac.org/en/oral-pcsk9-inhibitor-enlicitide-achieves-ldl-c-reduction-comparable-to-injectable-therapies/): Oral PCSK9 Inhibitor Enlicitide Achieves LDL-C Reduction Comparable to Injectable Therapies • Enlicitide is an experimental oral PCSK9 inhibitor from Merck that achieved ~57% LDL-C reduction at 24 weeks in a large trial (~3,000 patients), including patients who were statin-intolerant or on background statin therapy. • LDL lowering was sustained at 1 year, with improvements in ApoB and Lp(a). • Well tolerated, with no excess adverse events or diabetes signal. • Represents the largest LDL-C reduction ever reported with an oral agent since statins. • The observed LDL-C reduction (~57%) is of a magnitude comparable to that reported with parenteral […] - [Cardiology in the United States: A Subspecialty Today -A Specialty Tomorrow? Cardiology ](https://jordan-cardiac.org/en/cardiology-in-the-united-states-a-subspecialty-today-a-specialty-tomorrow-cardiology/): Cardiology in the United States: A Subspecialty Today -A Specialty Tomorrow? Cardiology Source: ACC Official Update (2026 ) (published days ago). Certification in the U.S. – Overview Current Structure • Cardiology is not an independent specialty. • It is a subspecialty of Internal Medicine. • Certification is granted by the American Board of Internal Medicine (ABIM). • Pathway: • 3 years Internal Medicine • 3 years Cardiology fellowship • ABIM Cardiovascular Disease exam • All subspecialties (Interventional, EP, HF, ACHD) remain under ABIM. • There is no independent American Board of Cardiology. Why It Is Being Debated • Cardiology has […] - [T. Fogarty, MD — Brief Legacy](https://jordan-cardiac.org/en/t-fogarty-md-brief-legacy/): T. Fogarty, MD — Brief Legacy • Passed away at the age of 91 • Pioneering cardiac and vascular surgeon and medical innovator • Inventor of the Fogarty balloon embolectomy catheter, which transformed treatment of acute arterial limb ischemia into a minimally invasive surgical procedure, performed via arteriotomy using a catheter, rapidly restoring blood flow and saving limbs • Key contributor to tissue heart valve development and to early EVAR technology • AneuRx stent graft (FDA-approved 1999) paved the way for modern EVAR = Endovascular Aneurysm Repair • EVAR: catheter-based stent grafts exclude the aneurysm from circulation, preventing rupture with […] - [Dyslipidemia back in focus](https://jordan-cardiac.org/en/dyslipidemia-back-in-focus/): Dyslipidemia back in focus • New ESC/EAS focused update (2025) is influencing upcoming AHA/ACC guidelines expected in early 2026. • Major advances since the last US update in 2019 support lower LDL-C targets in high-risk patients. • Updated risk assessment tools: SCORE2/SCORE2-OP in Europe; AHA PREVENT in the US. • Screening — when? • Start at age 20 for routine lipid screening. • Earlier only if high risk (strong family history, suspected familial hypercholesterolemia). • Repeat every 4–6 years if low risk; more often if risk is present. • Greater emphasis on risk enhancers, including: • Lp(a) elevation • CAC […] - [How Many Cups of Coffee Does It Take to Cause a Heart Attack?](https://jordan-cardiac.org/en/how-many-cups-of-coffee-does-it-take-to-cause-a-heart-attack/): How Many Cups of Coffee Does It Take to Cause a Heart Attack? • No increase in atrial fibrillation or PACs with coffee nor MI. • Small, clinically insignificant increase in PVCs. • Overall conclusion: • Coffee is not dangerous for the heart. • Take-home message: • Drink your coffee without fear — just not 1.7 million cups. Source& Date: January 23, 2026-Medscape Studies: 1) CRAVE Study (Coffee & Arrhythmias) 2) Baylin (Coffee & MI) https://www.medscape.com/viewarticle/how-many-cups-coffee-does-it-take-cause-heart-attack-2026a10001mu?utm_source=chatgpt.com - [‏Key Takeaways From the New Stroke Guideline :](https://jordan-cardiac.org/en/key-takeaways-from-the-new-stroke-guideline/): ‏Key Takeaways From the New Stroke Guideline: ‏ • Guideline update: The American Stroke Association (ASA), part of the American Heart Association, released updated ischemic stroke guidelines, published in Stroke. ‏ • Core principle: Coordinated systems of care (EMS, hospitals, telemedicine, stroke centers) save lives — “time is brain.” ‏ • Imaging timelines: ‏ • Initial brain imaging should occur within 25 minutes of hospital arrival. ‏ • Imaging requirements are simplified to allow more hospitals to act faster. ‏ • Thrombolysis: ‏Recommended within 4.5 hours of symptom onset. ‏ • Endovascular thrombectomy (EVT): Recommended for selected patients up to […] - [2026 – U.S. Cardiovascular Health Report “The Good, the Bad, and the Ugly” — JACC](https://jordan-cardiac.org/en/2026-u-s-cardiovascular-health-report-the-good-the-bad-and-the-ugly-jacc/): 2026 – U.S. Cardiovascular Health Report “The Good, the Bad, and the Ugly” — JACC Source: JACC, January 12, 2026 • Big picture: Despite past progress, cardiovascular outcomes are worsening in several areas, mainly due to aging, lifestyle factors, and system stress. • Hypertension: • ~1 in 3 patients are untreated. • Only ~2 out of 3 treated patients reach BP targets. • BP-related mortality has nearly doubled. → BP control remains a top priority in primary care. • Lipids (LDL-C): • Many patients with known ASCVD are still above LDL targets. • Statins and add-on therapies are underused. • […] - [2026 ACC/AHA Multisociety PAD Guidelines – Pharmacologic Therapy](https://jordan-cardiac.org/en/2026-acc-aha-multisociety-pad-guidelines-pharmacologic-therapy/): 2026 ACC/AHA Multisociety PAD Guidelines – Pharmacologic Therapy JACC | Just Accepted – January 8, 2026 Key Take-Home Messages • PAD is a high-risk systemic atherosclerotic disease → requires comprehensive medical therapy, not limb-focused treatment alone. • ACE inhibitors (or ARBs) • Class I indication – strong recommendation (should be used) in eligible PAD patients, unless contraindicated. • Considered first-line, evidence-based therapy, not optional. • Highlighted separately in PAD due to benefits beyond blood pressure control, including: • Anti-inflammatory effects • Prevention of adverse vascular remodeling • Improved endothelial function • Antiplatelet therapy • Aspirin or clopidogrel recommended for all […] - [CAD, without RIsk Factors(=SMuRF-Less )but Inflamed: Is Inflammation the Missing Link in Women’s Heart Disease?](https://jordan-cardiac.org/en/cad-without-risk-factorssmurf-less-but-inflamed-is-inflammation-the-missing-link-in-womens-heart-disease/): CAD, without RIsk Factors(=SMuRF-Less )but Inflamed: Is Inflammation the Missing Link in Women’s Heart Disease? Source: Medscape Medical News Date: January 8, 2026 Key Points • Major burden in women: • Despite this, women represent <40% of participants in cardiovascular clinical trials. • The SMuRF-less paradox: • Many women experience acute myocardial infarction (AMI) without standard modifiable risk factors (SMuRFs) such as hypertension, diabetes, dyslipidemia, or smoking. • SMuRF-less women have been shown to have up to threefold higher AMI mortality compared with men who have at least one traditional risk factor. • Inflammation as the missing risk factor: • […] - [IHD , without RIsk Factors( SMuRF-Less )but Inflamed: Is Inflammation the Missing Link in Women’s Heart Disease?](https://jordan-cardiac.org/en/ihd-without-risk-factors-smurf-less-but-inflamed-is-inflammation-the-missing-link-in-womens-heart-disease/): IHD , without RIsk Factors( SMuRF-Less )but Inflamed: Is Inflammation the Missing Link in Women’s Heart Disease? Source: Medscape Medical News Date: January 8, 2026 Key Points • Major burden in women: • Despite this, women represent <40% of participants in cardiovascular clinical trials. • The SMuRF-less paradox: • Many women experience acute myocardial infarction (AMI) without standard modifiable risk factors (SMuRFs) such as hypertension, diabetes, dyslipidemia, or smoking. • SMuRF-less women have been shown to have up to threefold higher AMI mortality compared with men who have at least one traditional risk factor. • Inflammation as the missing risk […] - [A Paradigm Shift in Nutrition: Real Food Over Fear of Fat](https://jordan-cardiac.org/en/a-paradigm-shift-in-nutrition-real-food-over-fear-of-fat/): A Paradigm Shift in Nutrition: Real Food Over Fear of Fat Source: Medscape, January 8, 2026 Key Points • Core shift in focus: • The 2025–2030 U.S. Dietary Guidelines move away from fat avoidance and prioritize reducing refined carbohydrates, added sugars, and ultra-processed foods as key drivers of metabolic disease, insulin resistance, and chronic inflammation. • Reframing dietary fats: • Natural saturated fats (eggs, meat, butter, whole-fat dairy) are no longer portrayed as inherently harmful. • Current evidence has not conclusively shown that these fats increase cardiovascular events or thrombosis, particularly considering limited absorption and metabolic handling, especially in lean […] - [FDA approves new venous stent for deep venous disease in Jan 2026 – Key Points](https://jordan-cardiac.org/en/fda-approves-new-venous-stent-for-deep-venous-disease-in-jan-2026-key-points/): FDA approves new venous stent for deep venous disease in Jan 2026 – Key Points • A first-of-its-kind FDA approval for a stent specifically designed for deep venous disease, rather than the traditional off-label use of arterial stents. • Designed to treat deep venous disease involving the IVC, iliac, and iliofemoral veins. • Self-expanding • Clinical evidence • FDA decision based on data presented at the VEINS Conference (Nov 2025). • International trial of 89 patients with deep venous disease. • 12-month primary patency: 83.4%. • No reported stent embolization/migration, fractures, vascular injuries, or clinically significant pulmonary embolism. https://www.beckershospitalreview.com/supply-chain/fda-approves-first-venous-stent-for-ivc-iliofemoral-use.html - [When BP Is 180/80: Which Drug Best Targets Systolic Hypertension?](https://jordan-cardiac.org/en/when-bp-is-180-80-which-drug-best-targets-systolic-hypertension/): When BP Is 180/80: Which Drug Best Targets Systolic Hypertension? Short Answer Thiazide-like diuretics provide the greatest and most consistent reduction in systolic blood pressure (SBP) and remain the most widely used first-line agents, particularly in isolated systolic hypertension. Why Thiazide-Like Diuretics Lead • Chlorthalidone and indapamide achieve the strongest SBP reduction • Best evidence in isolated systolic hypertension • Proven reduction in stroke and cardiovascular events • Recommended as first-line therapy across major guidelines How Other Agents Compare • Calcium Channel Blockers (CCBs) (e.g., amlodipine) • Highly effective for systolic BP • Especially beneficial in older adults • ACE […] - [Prediabetes Remission: Big CV Benefit (Very Short)](https://jordan-cardiac.org/en/prediabetes-remission-big-cv-benefit-very-short/): Prediabetes Remission: Big CV Benefit (Very Short) • Returning glucose to normal in prediabetes cuts MI, HF, and CV death by ~50%. • Based on long-term data (20–30 years) from US and China cohorts. • Benefit depends on glucose normalization, not lifestyle change alone. • Fasting glucose ≤97 mg/dL marks sustained lower CV risk. • Suggests a new prevention pillar alongside BP, LDL, and smoking. Source: The Lancet Diabetes & Endocrinology | Medscape News Europe Date: January 02, 2026 https://www.medscape.com/viewarticle/prediabetes-remission-halves-mi-and-hf-risk-lancet-study-2026a100001a?utm_source=chatgpt.com - [Restarting Anticoagulation After Brain Hemorrhage in AF (2025)](https://jordan-cardiac.org/en/restarting-anticoagulation-after-brain-hemorrhage-in-af-2025/): Restarting Anticoagulation After Brain Hemorrhage in AF (2025) Source: Medscape News UK Date: December 31, 2025 Journal: Therapeutic Advances in Neurological Disorders (Dec 21, 2025) Clinical Question • Should oral anticoagulants be restarted in patients with atrial fibrillation (AF) after intracerebral hemorrhage (ICH)? What the Study Found • Restarting anticoagulation: • ↓ Ischemic stroke by 80% (NNT = 9) • ↓ Ischemic MACE by 59% • But: • ↑ Recurrent ICH ~3-fold (NNH = 19) • ↑ Hemorrhagic MACE • No difference in: • All-cause mortality • Cardiovascular death Bottom Line • Restarting anticoagulation prevents strokes • But increases risk […] - [Blood Pressure Management in the First 24 Hours After Acute Ischemic Stroke](https://jordan-cardiac.org/en/blood-pressure-management-in-the-first-24-hours-after-acute-ischemic-stroke/): Blood Pressure Management in the First 24 Hours After Acute Ischemic Stroke Source: Medscape Medical News; ACC/AHA (2019 Stroke Guideline); ESO (European Stroke Organisation, 2021); ESC (ESC-aligned via ESO); ESH (2023 Hypertension Guideline); ISH (2020 Global Hypertension Guideline) Key points: • Do not aggressively lower BP in the first 24 hours after ischemic stroke. • Permissive hypertension is recommended to maintain cerebral perfusion. Blood pressure thresholds: • No thrombolysis planned: • Treat BP only if ≥220/120 mm Hg. • If treated, lower BP gradually (≈15% max in first 24 h). • IV thrombolysis (alteplase/tenecteplase): • BP must be <185/110 mm […] - [Should Aspirin Be Stopped Right After PCI? — Bullet Summary](https://jordan-cardiac.org/en/should-aspirin-be-stopped-right-after-pci-bullet-summary/): Should Aspirin Be Stopped Right After PCI? — Bullet Summary Source: Medscape Medical News (MedBrief) | Date: December 23, 2025 • Early aspirin stop risky: Higher ischemic events in the first 30 days vs standard DAPT. • Bleeding benefit: Monotherapy reduced bleeding early and late. • After 30 days: Ischemic outcomes similar between groups. • Net benefit later: Fewer net adverse events with monotherapy from 1–12 months. • Clinical message: Keep DAPT for the first month post-ACS PCI; avoid very early aspirin discontinuation. https://click.mail.medscape.com/?qs=dc18bc19d19a2318157f68c206173ec2a8c740510647413ea012449849642bacd0e24cca3d91cbf02dfec03af6913aab3617d3a14365bec76cea31ea139d9d3a - [Cold Weather & Cardiovascular Risk.](https://jordan-cardiac.org/en/cold-weather-cardiovascular-risk/): Cold Weather & Cardiovascular Risk. Source: Medscape Medical News | Date: December 22, 2025 • Cold increases CV risk: Higher rates of MI during cold spells (≈10%↑; prolonged cold ≈18%↑). • Physiologic effects: Sympathetic activation → vasoconstriction, ↑ BP (15–20 mm Hg), ↑ HR. • Heart workload: Higher BP and resistance raise myocardial oxygen demand → angina/MI risk. • Exercise + cold: Additive BP rise, especially with snow shoveling (up to +37 mm Hg). • High-risk groups: ASCVD, heart failure, older adults, low fitness. • Key advice: Dress warmly, avoid strenuous outdoor exertion, limit alcohol. • Red flags: Chest pain, […] - [Match Day 2025: High Success Rates, But a Growing Shortage in Interventional Cardiology](https://jordan-cardiac.org/en/match-day-2025-high-success-rates-but-a-growing-shortage-in-interventional-cardiology/): Match Day 2025: High Success Rates, But a Growing Shortage in Interventional Cardiology Source: SCAI (Official Statements), December 2025 ‏ Link: https://scai.org/news Key Highlights: • Match Day is the official day doctors learn where they are accepted for residency or fellowship training; results are released on one fixed day per program. • More than 150 interventional cardiology programs participated in the 2025 Match Day. • Despite a 97% match rate, 71 fellowship positions remained unfilled across 49 programs, reflecting fewer doctors entering the specialty. • The key concern is having enough trained doctors in the future, driven by heavy workload, radiation […] - [How Well Do You Know the New Hypertension Guidelines?](https://jordan-cardiac.org/en/how-well-do-you-know-the-new-hypertension-guidelines/): How Well Do You Know the New Hypertension Guidelines? Source: AHA/ACC and partner societies. Issued: 2025 Medscape: December 9, 2025 Key Takeaways : • Stage 2 hypertension requires immediate evaluation and escalation treatment. • Secondary hypertension accounts for 5–25% of cases. • OSA is common (up to 50%); • Primary aldosteronism affects 5–10% and doubles cardiovascular risk versus primary hypertension. • Aldosterone–renin ratio (ARR) is the preferred screening test; most medications usually do not need to be stopped. • Hypokalemia may suggest aldosteronism but is often absent. • Renal artery disease: Renovascular disease is common on imaging but rarely clinically […] - [How Potassium Counters Sodium: Sex-Specific Mechanisms and Clinical Implications for Blood Pressure Control](https://jordan-cardiac.org/en/how-potassium-counters-sodium-sex-specific-mechanisms-and-clinical-implications-for-blood-pressure-control-2/): How Potassium Counters Sodium: Sex-Specific Mechanisms and Clinical Implications for Blood Pressure Control Source: ISH – December 2025 Key notes: • Salt sensitivity varies: Blood pressure responses to sodium differ by age, ethnicity, kidney function, obesity, and other factors. • Only ~50% of hypertensive patients are salt-sensitive, yet reducing excessive sodium intake is recommended for most. • Potassium counteracts sodium: Increased potassium intake can blunt or even reverse sodium-induced BP elevation, even with high sodium intake. • Sex-specific mechanisms: • Men: BP response driven mainly by proximal renal sodium transport. • Women: Distal sodium transport predominates, resulting in a more […] - [Should BP Be Lowered in Isolated Diastolic Hypertension? ](https://jordan-cardiac.org/en/should-bp-be-lowered-in-isolated-diastolic-hypertension/): Should BP Be Lowered in Isolated Diastolic Hypertension? Source (Secondary): Medscape , December 17, 2025 Primary Source: European Heart Journal Dec— Key Points • Large evidence base: Individual participant data meta-analysis of 51 randomized controlled trials including 358,325 adults. • Definition used: Isolated diastolic hypertension (IDH) = SBP <130 mm Hg with DBP ≥80 mm Hg (alternative definition also tested). • Population: Only 4.4% had IDH, but outcomes were robust across subgroups. • Main finding: • A 5-mm Hg reduction in systolic BP was associated with an approximately 10% reduction in major cardiovascular events, both in patients with and without […] - [Proposed National System for Early Identification and Diagnosis of Heart Failure in Jordan](https://jordan-cardiac.org/en/proposed-national-system-for-early-identification-and-diagnosis-of-heart-failure-in-jordan-2/): Proposed National System for Early Identification and Diagnosis of Heart Failure in Jordan Source: Taskforce Proposal for Implementing National HF Protocols (JCS 2025) 1. Background and Purpose Early detection of heart failure (HF) in primary care is increasingly important given rising rates of hypertension, diabetes, obesity, and chronic kidney disease. National and international guidance emphasizes targeted early detection rather than mass screening. The following summarizes the proposed national approach. 2. Screening Strategy and Recommendations Population-wide screening for HF is not recommended by current guidelines. Targeted early detection among high-risk individuals is strongly supported. Core tools include symptom checklist, focused examination, […] - [HFpEF: Common Disease, Uncommon Diagnosis](https://jordan-cardiac.org/en/hfpef-common-disease-uncommon-diagnosis/): HFpEF: Common Disease, Uncommon Diagnosis Source: Medscape Medical News Date: December 09, 2025 Keynotes:  1.⁠ ⁠HFpEF: A Rising Clinical Challenge • HFpEF causes HF symptoms despite LVEF ≥ 50% due to elevated LV filling pressures. • HFpEF is commonly underdiagnosed because its symptoms resemble those of many noncardiac illnesses. • Prevalence is rising, especially in older adults, women, and obesity.  2.⁠ ⁠Why Diagnosis Is Often Missed or Delayed • One-third of HFpEF patients have normal filling pressures at rest; abnormalities appear only during exercise. • Patients with obesity waited 22 months on average to receive the correct diagnosis. • Many […] - [Proposed National System for Early Identification and Diagnosis of Heart Failure in Jordan](https://jordan-cardiac.org/en/proposed-national-system-for-early-identification-and-diagnosis-of-heart-failure-in-jordan/): Proposed National System for Early Identification and Diagnosis of Heart Failure in Jordan Source: Taskforce Proposal for Implementing National HF Protocols (JCS 2025) 1.⁠ ⁠Background and Purpose Early detection of heart failure (HF) in primary care is increasingly important given rising rates of hypertension, diabetes, obesity, and chronic kidney disease. The national question was: Is there a simple screening or assessment tool that can be used for early detection of HF in primary care? The following summarizes the proposed national approach. 2.⁠ ⁠Do We Need a Screening Test? What Is Recommended? 1. Current national and international guidelines do not recommend […] - [Why Heart Failure Protocols Matter: Global Evidence That GDMT Underuse Is a Worldwide Problem (2025)](https://jordan-cardiac.org/en/why-heart-failure-protocols-matter-global-evidence-that-gdmt-underuse-is-a-worldwide-problem-2025/): Why Heart Failure Protocols Matter: Global Evidence That GDMT Underuse Is a Worldwide Problem (2025) Three major 2025 studies show clearly that underuse of GDMT is a global problem, spanning low-resource settings, primary care systems, and advanced European centers. National protocols are the proven first step to closing this implementation gap. Keynotes: 1) Implementation of Guideline-Directed Medical Therapy in HFrEF Journal: BMC Cardiovascular Disorders Date: October 2025 Setting: Hospital-based cohort in Ethiopia Link: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-05187-5 Summary: • Only 1.3% of patients reached full target GDMT doses (RASI, β-blocker, MRA). • 0% received ARNI or SGLT2i due to cost and limited availability. […] - [Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025)](https://jordan-cardiac.org/en/potassium-enriched-salt-in-hypertension-management-hypertension-news-dec-2025/): Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025) 1.⁠ ⁠Background: Why Potassium-Enriched Salt? • High sodium intake remains a major global driver of hypertension, CVD, and premature death. • No country is on track to meet WHO salt-reduction targets (2025/2030). • Low potassium intake is an under-recognized but equally important BP risk factor. • Most populations consume far below the WHO potassium recommendation (3.5 g/day). 2.⁠ ⁠What Is Potassium-Enriched Salt? • Regular salt with part of NaCl replaced by KCl (e.g., 75% NaCl / 25% KCl). • Maintains salty taste → increases acceptability. • Available as “Lo Salt,” “Lite […] - [BIHS 2025 Position Statement on BP Treatment Thresholds and Targets](https://jordan-cardiac.org/en/bihs-2025-position-statement-on-bp-treatment-thresholds-and-targets/): BIHS 2025 Position Statement on BP Treatment Thresholds and Targets Source: Hypertension News, ISH – December 2025 Key Concepts & Updates 1.⁠ ⁠Shift Toward More Aggressive BP Treatment • The British and Irish Hypertension Society (BIHS) is the latest to call for lower treatment thresholds and tighter BP targets. • New treatment threshold: ≥135/85 mmHg for diagnosing hypertension (regardless of BP measurement method). • New treatment target: <130/80 mmHg for all hypertensive patients, irrespective of risk category or measurement method. • This marks a significant shift aligning with a global trend toward earlier and more intensive BP management. 2.⁠ ⁠Evidence […] - [How Potassium Counters Sodium: Sex-Specific Mechanisms and Clinical Implications for Blood Pressure Control](https://jordan-cardiac.org/en/how-potassium-counters-sodium-sex-specific-mechanisms-and-clinical-implications-for-blood-pressure-control/): How Potassium Counters Sodium: Sex-Specific Mechanisms and Clinical Implications for Blood Pressure Control Source: Hypertension News, ISH – December 2025 Key notes: • Potassium blunts or even reverses sodium-induced blood pressure elevations, even when sodium intake remains high. Sex Differences • Females show a more attenuated BP rise with sodium load. • Mechanistic differences: •⁠  ⁠Males → proximal Na⁺ transport dominates •⁠  ⁠Females → distal Na⁺ transport more influential Clinical Implications • Increasing dietary potassium (fruits, vegetables, K-enriched salt) is a powerful, physiologically grounded BP-lowering strategy. • Potassium can neutralize the hypertensive effects of high sodium, supporting global dietary recommendations. […] - [Diagnosis & Treatment of Renal Artery Stenosis (RAS)](https://jordan-cardiac.org/en/diagnosis-treatment-of-renal-artery-stenosis-ras/): Diagnosis & Treatment of Renal Artery Stenosis (RAS) Source (Hypertension News – Dec 2025) Keynotes: 1.⁠ ⁠Types of Renal Artery Stenosis • Atherosclerotic RAS (ARAS): majority of cases; driven by flow disturbances + intrarenal inflammation. • Fibromuscular Dysplasia (FMD): increasingly recognized; kidney structure preserved, similar to essential hypertension. 2.⁠ ⁠When to Suspect RAS Key clinical clues: • Resistant or sudden-onset hypertension • Ischemic nephropathy or unexplained decline in eGFR • “Cardiac destabilization syndromes”: flash pulmonary edema, recurrent HF, ACS • Abdominal bruit, unexplained hypokalemia • Strongest predictors of significant RAS: • Kidney length asymmetry ≥10% • Peripheral / extra-renal atherosclerosis […] - [Esaxerenone +/– SGLT2i in Hypertensive T2DM Patients](https://jordan-cardiac.org/en/esaxerenone-sglt2i-in-hypertensive-t2dm-patients/): Esaxerenone +/– SGLT2i in Hypertensive T2DM Patients Source: Hypertension News – International Society of Hypertension, December 2025 Keynotes : • Study type: pooled analysis of 5 prospective clinical studies (≈280 patients). • Drug: Esaxerenone — a nonsteroidal mineralocorticoid receptor blocker (MRB). • Population: Hypertensive patients with type 2 diabetes — with and without SGLT2 inhibitor therapy. 1.⁠ ⁠Blood Pressure Reduction • Significant BP drop by week 12 in all groups. • Overall: −11.9 / −5.2 mmHg • With SGLT2i: −11.3 / −4.8 mmHg • Without SGLT2i: −12.5 / −5.7 mmHg • ~70% achieved home BP target <135/85 mmHg. 2.⁠ ⁠Kidney […] - [Multisociety Hypertension Guidelines (Messages to the World)](https://jordan-cardiac.org/en/multisociety-hypertension-guidelines-messages-to-the-world/): Multisociety Hypertension Guidelines (Messages to the World) Source: Hypertension News – December 2025 Keynotes :  1.⁠ ⁠Broad, Multidisciplinary U.S. Effort • Guideline developed with 11 U.S. societies (cardiology, nephrology, geriatrics, neurology, pharmacy, nursing, general practice). • Reflects a team-based, population-level strategy for a country where >45% of adults meet hypertension criteria.  2.⁠ ⁠Blood Pressure Measurement & Diagnosis • Use validated automated office devices; avoid cuffless devices. • ABPM/HBPM required in most patients for diagnosis and titration. • ABPM has stronger evidence, but HBPM is more practical and widely recommended.  3.⁠ ⁠Screening for Primary Aldosteronism • Broader screening indications: resistant HTN, […] - [Home Messages — Siemens + Stryker Neurovascular Robotics Collaboration Source: (Medical News – Technology, 2025:](https://jordan-cardiac.org/en/home-messages-siemens-stryker-neurovascular-robotics-collaboration-source-medical-news-technology-2025/): Home Messages — Siemens + Stryker Neurovascular Robotics Collaboration Source: (Medical News – Technology, 2025: •⁠  ⁠Siemens and : •⁠  ⁠Stryker Neurovascular Newsroom,2025) • Siemens Healthineers and Stryker are partnering to develop a next-generation neurovascular robotic system designed to treat stroke, aneurysms, and other high-risk vascular conditions. • The goal is to create a unified ecosystem combining imaging, robotics, and therapeutic devices—enabling faster, more precise neurovascular interventions. • Siemens contributes advanced imaging and robotics, while Stryker brings deep expertise in neurovascular devices, making this a highly complementary partnership. • The robot is being developed with direct physician input, ensuring that […] - [Home Messages — Interventional Cardiology’s Shift Toward Endovascular Therapies (TCT 2025)](https://jordan-cardiac.org/en/home-messages-interventional-cardiologys-shift-toward-endovascular-therapies-tct-2025/): Home Messages — Interventional Cardiology’s Shift Toward Endovascular Therapies (TCT 2025)  keynotes:       • Endovascular medicine is becoming a central pillar of interventional cardiology, with growing focus on pulmonary embolism (PE), stroke, PAD, carotid disease, and renal denervation. • STORM-PE is the first randomized trial of mechanical thrombectomy for intermediate-risk PE, showing meaningful right-heart strain reduction and signaling a potential shift in future PE guidelines. • LIFE-BTK demonstrated sustained benefit at 3 years from a resorbable drug-eluting scaffold for below-the-knee intervention—even after the device has fully dissolved. • Vascular sessions at TCT 2025 were packed, reflecting a renewed […] - [Combined Mitral–Tricuspid TEER Using One Guide Catheter (STriC-TEER)](https://jordan-cardiac.org/en/combined-mitral-tricuspid-teer-using-one-guide-catheter-stric-teer/): Combined Mitral–Tricuspid TEER Using One Guide Catheter (STriC-TEER) Source: Circulation: Cardiovascular Interventions -16 Nov. ,2025 Medical News: November 24, 2025 Key Points 1. New Technique: Uses one TriClip steerable guide catheter (SGC)—originally designed for tricuspid TEER—to perform both MitraClip (mitral) and TriClip (tricuspid) repairs in the same session. 2. How It Works : • Start MitraClip through the TriClip SGC in the left atrium. • Withdraw the MitraClip system. • Pull the same SGC back into the right atrium. • Insert TriClip through the same SGC and complete T-TEER. 3. Study: 40 patients (mean age 76، treated in Hong Kong, […] - [Adjustable-Size Interatrial Shunt Demonstrates Early Feasibility in Heart Failure. First-in-human trial. Source : Medical News,November 25, 2025](https://jordan-cardiac.org/en/adjustable-size-interatrial-shunt-demonstrates-early-feasibility-in-heart-failure-first-in-human-trial-source-medical-newsnovember-25-2025/): Adjustable-Size Interatrial Shunt Demonstrates Early Feasibility in Heart Failure. First-in-human trial. Source : Medical News,November 25, 2025 Keynotes : 1. First-in-human trial tested a new adjustable interatrial shunt for advanced heart failure. 2. Device can change size over time and continuously measures atrial pressures. 3. Implanted successfully in 10 patients with no major complications. 4. At 90 days: shunt size could be readjusted in all patients, and pressures were sent remotely. 5. Early signs: patients felt better and natriuretic peptides dropped. 6. A new study (ATLANTIS) is enrolling more patients. 7. Interatrial shunts aim to reduce high left atrial pressure, […] - [Cardiology Workplace Survey in JACC article.](https://jordan-cardiac.org/en/cardiology-workplace-survey-in-jacc-article/): Cardiology Workplace Survey in JACC article. Source: Medical News ,based on JACC-17 November 2025 Keynotes: 1. Doctors were divided into 4 groups: • 29% said cardiology is supportive and welcoming and nothing needs to change. • 33% said cardiology is supportive and welcoming, but some improvements are needed. • 19% felt the field is difficult and not welcoming and are unsure what to fix. • 18% felt the field is difficult, unfair and not welcoming and major changes are needed. 2. Problems experienced by doctors: • 45% treated badly • 23% faced unfair treatment (discrimination) • 19% emotional or physical […] - [EARLY TAVR – Ultra-Short Summary](https://jordan-cardiac.org/en/early-tavr-ultra-short-summary/): EARLY TAVR – Ultra-Short Summary Source: Medical News (29 Oct 2025), based on EuroPCR 2025 analyses and TCT Late-Breaking Trial presentations ; original EARLY TAVR publications in The New England Journal of Medicine (NEJM) and JACC: Cardiovascular Interventions (2024) Keynotes: 1. Early TAVR is superior: Reduced death/stroke/unplanned CV hospitalization (26.8% vs 45.3%). (NEJM) 2. Fewer hospitalizations: Unplanned CV admissions almost halved (20.9% vs 41.7%). (NEJM) 3. Better quality of life: Favorable outcomes at 2 years: 86.6% vs 68%. (NEJM) 4. Waiting is unsafe: Surveillance patients rapidly deteriorated: 25% needed TAVR at 6 months, 71% by 2 years. (NEJM) 5. Delayed […] - [APSC Cloud webinar entitled " Implementing Recent Innovative Technologies in Cardiac Arrhythmia Treatment in 2025 : Skills & Tricks " on Dec. 10 (Wed), 2025](https://jordan-cardiac.org/en/apsc-cloud-webinar-entitled-implementing-recent-innovative-technologies-in-cardiac-arrhythmia-treatment-in-2025-skills-tricks-on-dec-10-wed-2025-2/): APSC Cloud webinar entitled ” Implementing Recent Innovative Technologies in Cardiac Arrhythmia Treatment in 2025 : Skills & Tricks ” on Dec. 10 (Wed), 2025 Dear All Friends of the APSC and Member Societies: The APSC Cloud Forum of Cardiovascular Diseases is to hold a new webinar entitled ” Implementing Recent Innovative Technologies in Cardiac Arrhythmia Treatment in 2025 : Skills & Tricks ” scheduled on December 10 (Wed), 2025, at 08:00 AM-10:10 AM ( UAE, GMT+4 ) and 12:00 PM-14:10 PM ( Brunei, Philippines, Singapore, Taiwan, GMT+8 ) . The Opening Chairperson is Dr Kenny Tan ( Singapore ) […] - [APSC Cloud webinar entitled " Implementing Recent Innovative Technologies in Cardiac Arrhythmia Treatment in 2025 : Skills & Tricks " on Dec. 10 (Wed), 2025](https://jordan-cardiac.org/en/apsc-cloud-webinar-entitled-implementing-recent-innovative-technologies-in-cardiac-arrhythmia-treatment-in-2025-skills-tricks-on-dec-10-wed-2025/): APSC Cloud webinar entitled ” Implementing Recent Innovative Technologies in Cardiac Arrhythmia Treatment in 2025 : Skills & Tricks ” on Dec. 10 (Wed), 2025 Dear All Friends of the APSC and Member Societies: The APSC Cloud Forum of Cardiovascular Diseases is to hold a new webinar entitled ” Implementing Recent Innovative Technologies in Cardiac Arrhythmia Treatment in 2025 : Skills & Tricks ” scheduled on December 10 (Wed), 2025, at 08:00 AM-10:10 AM ( UAE, GMT+4 ) and 12:00 PM-14:10 PM ( Brunei, Philippines, Singapore, Taiwan, GMT+8 ) . The Opening Chairperson is Dr Kenny Tan ( Singapore ) […] - [AHA 2025 – PCSK9 Inhibitors & Enlicitide (Oral PCSK9i)](https://jordan-cardiac.org/en/aha-2025-pcsk9-inhibitors-enlicitide-oral-pcsk9i/): AHA 2025 – PCSK9 Inhibitors & Enlicitide (Oral PCSK9i) Source: theheart.org on Medscape — Nov 24, 2025 1. VESALIUS-CV: Evolocumab lowered MACE in high-risk primary-prevention patients, with signals of reduced mortality. 2. LDL principle: Lower LDL-C consistently reduces events across all risk levels — no real primary vs secondary separation. 3. Underuse: PCSK9 inhibitors remain rarely prescribed despite improved access and low cost; injections and clinic time are major barriers. 4. Enlicitide (oral PCSK9i): Phase 3 shows LDL-C reduction equal to monoclonal antibodies with strong adherence and excellent safety. 5. Combination therapy: Target-based LDL-C management is preferred; stepwise escalation often […] - [Lowering LDL Cholesterol Linked to 25% Lower Stroke Risk](https://jordan-cardiac.org/en/lowering-ldl-cholesterol-linked-to-25-lower-stroke-risk-2/): Lowering LDL Cholesterol Linked to 25% Lower Stroke Risk Author: Deborah Brauser Source: Medscape Medical News – AHA Scientific Sessions 2025 Date: November 11, 2025 Keynotes: 1)   • Achieving LDL < 40 mg/dL in patients with prior ischemic stroke significantly reduces: • 31% ↓ MACE • 27% ↓ all strokes • 25% ↓ ischemic stroke • No increase in hemorrhagic stroke risk. 2) Study Details • Data from 5291 patients (FOURIER + FOURIER-OLE). • Follow-up: 7–8 years. • Benefit increased stepwise as LDL decreased (“the lower, the better”). • Even <20 mg/dL showed no safety signal. 3) Clinical Meaning • […] - [Lowering LDL Cholesterol Linked to 25% Lower Stroke Risk](https://jordan-cardiac.org/en/lowering-ldl-cholesterol-linked-to-25-lower-stroke-risk/): Lowering LDL Cholesterol Linked to 25% Lower Stroke Risk Author: Deborah Brauser Source: Medscape Medical News – AHA Scientific Sessions 2025 Date: November 11, 2025 Keynotes: 1)   • Achieving LDL < 40 mg/dL in patients with prior ischemic stroke significantly reduces: • 31% ↓ MACE • 27% ↓ all strokes • 25% ↓ ischemic stroke • No increase in hemorrhagic stroke risk. 2) Study Details • Data from 5291 patients (FOURIER + FOURIER-OLE). • Follow-up: 7–8 years. • Benefit increased stepwise as LDL decreased (“the lower, the better”). • Even <20 mg/dL showed no safety signal. 3) Clinical Meaning • […] - [Drone-Delivered AEDs Begin First U.S. Trial to Cut Response Times](https://jordan-cardiac.org/en/drone-delivered-aeds-begin-first-u-s-trial-to-cut-response-times-2/): Drone-Delivered AEDs Begin First U.S. Trial to Cut Response Times Source: Duke Health News, November 19, 2025 Keynotes: 1. Cardiac arrest survival is <10% among 350,000 yearly U.S. cases. 2. Early AED use (2–3 minutes) can raise survival to up to 70% (prior research). 3. EMS response averages 8–10 minutes, missing the optimal window. 4. Duke Health launched the first U.S. trial of drone-delivered AEDs during real 911 calls. 5. Drones aim to deliver AEDs in under 5 minutes, vs conventional EMS. 6. Drones fly autonomously and winch the AED to the ground safely without landing. 7. For legal and […] - [Management of Arrhythmias During Pregnancy – Key Points](https://jordan-cardiac.org/en/management-of-arrhythmias-during-pregnancy-key-points/): Management of Arrhythmias During Pregnancy – Key Points Source: 2025 ESC Guidelines on CVD in pregnancy, supported by the November 2025 analysis on arrhythmias in pregnancy (J Multidiscip Healthc). Keynotes:  1.⁠ ⁠Importance of the Consensus • Provides the first unified, multidisciplinary approach (EP, OB, neonatology, genetics). • Summarizes limited evidence into clear, graded recommendations. • Acts as a practical one-stop reference for managing maternal and fetal arrhythmias.  2.⁠ ⁠Most Common Presentation • Palpitations are the most common cardiac symptom in pregnancy. • Only ~10% show a true arrhythmia on ECG/monitoring. • Most detected rhythms are benign (sinus tachycardia, PACs).  3.⁠ […] - [Management of rrhythmias During Pregnancy Management of Arrhythmias During Pregnancy – Key Points](https://jordan-cardiac.org/en/9250/): Management of rrhythmias During Pregnancy Management of Arrhythmias During Pregnancy – Key Points   Source: 2025 ESC Guidelines on CVD in pregnancy, supported by the November 2025 analysis on arrhythmias in pregnancy (J Multidiscip Healthc). Keynotes: 1. Importance of the Consensus • Provides the first unified, multidisciplinary approach (EP, OB, neonatology, genetics). • Summarizes limited evidence into clear, graded recommendations. • Acts as a practical one-stop reference for managing maternal and fetal arrhythmias. 2. Most Common Presentation • Palpitations are the most common cardiac symptom in pregnancy. • Only ~10% show a true arrhythmia on ECG/monitoring. • Most detected rhythms […] - [Drone-Delivered AEDs Begin First U.S. Trial to Cut Response Times](https://jordan-cardiac.org/en/drone-delivered-aeds-begin-first-u-s-trial-to-cut-response-times/): Drone-Delivered AEDs Begin First U.S. Trial to Cut Response Times Drone-Delivered AEDs: Cutting 911 Response Time in the First U.S. Trial Drone-Delivered AEDs Begin First U.S. Trial to Cut Response Times Source: Duke Health News, November 19, 2025 Keynotes: 1. Cardiac arrest survival is <10% among 350,000 yearly U.S. cases. 2. Early AED use (2–3 minutes) can raise survival to up to 70% (prior research). 3. EMS response averages 8–10 minutes, missing the optimal window. 4. Duke Health launched the first U.S. trial of drone-delivered AEDs during real 911 calls. 5. Drones aim to deliver AEDs in under 5 minutes, […] - [Lower LDL Cholesterol Cuts Stroke Risk by 25%](https://jordan-cardiac.org/en/lower-ldl-cholesterol-cuts-stroke-risk-by-25/): Lower LDL Cholesterol Cuts Stroke Risk by 25%\\ Lowering LDL Cholesterol Linked to 25% Lower Stroke Risk Source: Medscape Medical News – AHA Scientific Sessions 2025 (November 11, 2025) Keynotes: 1) Achieving LDL < 40 mg/dL in patients with prior ischemic stroke significantly reduces: • 31% ↓ MACE • 27% ↓ all strokes • 25% ↓ ischemic stroke • No increase in hemorrhagic stroke risk. Study Details • Data from 5291 patients (FOURIER + FOURIER-OLE). • Follow-up: 7–8 years. • Benefit increased stepwise as LDL decreased (“the lower, the better”). • Even <20 mg/dL showed no safety signal. Clinical Meaning […] ## Pages - [Scientific materials 2](https://jordan-cardiac.org/en/scientific-materials-2/): Dyslipidemia Management Hypertension Clinical Protocols LAAO (Watchman) vs DOAC (CHAMPION-AF): Catheter-Directed Therapy vs Anticoagulation in Intermediate-Risk PE (HI-PEITHO): ACC 2026 Scientific sessions, March 29, 2026) Angio-Derived FFR -ACC 2026 Practice-Changing Interventional Cardiology — ACC.26 (Bullet Summary) Impella + PCI vs PCI Alone (STEMI-DTU): No Benefit… More Harm LDL - [UpToDate](https://jordan-cardiac.org/uptodate/) - [سياسة التسليم (Delivery Policy)](https://jordan-cardiac.org/delivery-policy/): Delivery Policy At Jordan Cardiac Society, we strive to provide convenient methods for receiving membership or affiliation cards. The cards will be delivered according to the following options: 1. Electronic Delivery via Email After successfully completing the registration or membership renewal, your membership or affiliation card will be sent electronically to the registered email address. Please ensure that your email address is accurate and up-to-date to guarantee timely delivery. Electronic delivery time: The electronic card will be sent to your email within 5 business days after the order is confirmed. 2. In-Person Delivery at the Society’s Office For members who […] - [سياسة الإلغاء (Cancellation Policy)](https://jordan-cardiac.org/cancellation-policy/): Cancellation Policy Service Cancellation Customers can cancel their subscription to services or events at least 7 days before the scheduled service. The cancellation request can be submitted by contacting us at 00962795001983. Cancellation Terms If the service is canceled more than 7 days before the scheduled date, the full amount will be refunded. If the service is canceled within less than 7 days of the scheduled date, 50% of the paid fees will be deducted. If the cancellation occurs less than 48 hours before the scheduled service or in case of no-show, no refund will be issued. Cancellation by the […] - [سياسة الاسترجاع (Refund Policy)](https://jordan-cardiac.org/refund-policy/): Refund Policy At Jordan Cardiac Society, we are committed to providing high-quality medical and educational services. If you are not satisfied with any of our services, please read the refund policy carefully. Non-Refundable Services Due to the nature of the services provided by the Society, which include medical lectures, seminars, and consultations, all fees paid for these services are considered final and non-refundable, except in exceptional cases where a refund request will be reviewed based on the reasons provided. Refund Requests If you believe you are eligible for a refund due to exceptional circumstances, you can submit a refund request […] - [الشروط والأحكام (Terms and Conditions)](https://jordan-cardiac.org/%d8%a7%d9%84%d8%b4%d8%b1%d9%88%d8%b7-%d9%88%d8%a7%d9%84%d8%a3%d8%ad%d9%83%d8%a7%d9%85/): Terms and Conditions Welcome to Jordan Cardiac Society! These terms and conditions govern your use of the Jordan Cardiac Society platform, owned and operated by the Society. By using or accessing the Jordan Cardiac Society platform, you agree to fully comply with these terms. If you do not agree with any part of these terms, you must stop using the platform. 1. Acceptance of Terms By using or accessing the Jordan Cardiac Society platform, you agree to be bound by these terms and conditions, as well as any additional policies referenced herein. These terms apply to all users of the […] - [General Payment Service via Cliq](https://jordan-cardiac.org/en/general-payment-service-via-cliq/): Dear Colleagues, Members of the Jordanian Heart Association Greetings and after, We would like to inform you that the Jordanian Heart Association has activated the payment service for the association through Click under the name CARDIAC in order to facilitate doctors to pay their subscriptions and benefit from attending scientific and social activities and conferences and benefit from the hours approved for these activities Chairman and members of the Administrative Board - [خدمة الدفع للجمعية عن طريق كليك](https://jordan-cardiac.org/%d8%ae%d8%af%d9%85%d8%a9-%d8%a7%d9%84%d8%af%d9%81%d8%b9-%d9%84%d9%84%d8%ac%d9%85%d8%b9%d9%8a%d8%a9-%d8%b9%d9%86-%d8%b7%d8%b1%d9%8a%d9%82-%d9%83%d9%84%d9%8a%d9%83/): الزميلات والزملاء أعضاء جمعية القلب الأردنية المحترمين تحية طيبة وبعد ،، نود إعلامكم بان جمعية أطباء القلب الأردنية قامت بتفعيل خدمة الدفع للجمعية عن طريق كليك وذلك تحت المسمى CARDIAC وذلك من التسهيل على الأطباء لتسديد اشتراكاتهم والاستفادة من حضور النشاطات العلمية والاجتماعية وحضور المؤتمرات والاستفادة من الساعات المعتمدة لهذه النشاطات رئيس وأعضاء الهيئة الادارية - [Videos](https://jordan-cardiac.org/videos/) - [Photos](https://jordan-cardiac.org/photos/) - [Scientific materials](https://jordan-cardiac.org/en/%d9%85%d9%88%d8%a7%d8%af-%d8%b9%d9%84%d9%85%d9%8a%d8%a9-2/): Valvular heart diseases Cardiac Arrythmias Cardiomyopathy Congestive heart failure ECG (EKG) Hypertension Infective endocarditis ISCHEMIA. Pericarditis مجلة أبحاث أمراض القلب والأوعية الدموية MORTALITY OF CARDIOVASCULAR DISEASES IN GAZA DURING THE ISRAELI MILITARY OPERATION There’s no evidence to support A. Stopping DOACS 4, 5, or 7 days as some surgeons recommend. B. Bridging with LMWH. Take-home-message ESC – European Society of Cardiology Summaries about chest pain units الرسالة الأساسية من الدراسه  – Take Home Message Chest Pain Risk Stratification in the Emergency Department: Current Perspectives ECG features increasing the likelihood of VT Top 10 Take-Home Messages FROM THE AHA 24 New […] - [مواد علمية](https://jordan-cardiac.org/%d9%85%d9%88%d8%a7%d8%af-%d8%b9%d9%84%d9%85%d9%8a%d8%a9-2/): Valvular heart diseases Cardiac Arrythmias Cardiomyopathy Congestive heart failure ECG (EKG) Hypertension Infective endocarditis ISCHEMIA Pericarditis مجلة أبحاث أمراض القلب والأوعية الدموية MORTALITY OF CARDIOVASCULAR DISEASES IN GAZA DURING THE ISRAELI MILITARY OPERATION التوصيات الموحدة الصادرة عن مؤتمر إطلاق البروتوكول الوطني للتعامل مع مريض ألم الصدر الوطني واجتماع الطاولة المستديرة - [نبذة عنا - About us](https://jordan-cardiac.org/aboutus/): A Detailed Overview of the Jordanian Cardiac Society The Jordanian Cardiac Society (JCS) stands as one of the most significant medical and non-profit health organizations in Jordan. It serves cardiologists within the kingdom and the Arab world, as well as the general public. The association encompasses various specialized working groups focusing on key cardiology fields, including interventional cardiology, heart failure, electrophysiology, valvular heart disease, hypertension, amyloidosis, and advanced cardiac imaging techniques like nuclear, magnetic, and echocardiography imaging Objectives of the Jordanian Heart Association  :Enhancing Physicians’ Skills JCS is committed to improving the skills of cardiologists by modernizing education and training […] - [اضافة عضو](https://jordan-cardiac.org/users/) - [Lectures and conferences](https://jordan-cardiac.org/en/lectures-and-conferences/): Previous lectures and conferences The Jordanian Cardiac Society Signs Affiliation Agreement with MDPI Publishing Cooperation Agreement Between the Jordan Cardiac Society (JCS) and UpToDate to Support Physicians. The Jordanian Cardiac Society (JCS) and the American Heart Association (AHA) Collaborate to Enhance Cardiovascular Care and Public Health Education A specialized cardiac medical examination The Jordanian Cardiac Society (JCS) The Cardiology 26 /Feb 2024 Charity Medicine Bank Charity Medicine Bank Upcoming lectures and conferences Cath conference 29/1/2025 – Fairmont hotel International conference of the Jordan cardiac society document.createElement(‘video’);… International conference of the Jordan cardiac society - [محاضرات ومؤتمرات](https://jordan-cardiac.org/%d9%85%d8%ad%d8%a7%d8%b6%d8%b1%d8%a7%d8%aa-%d9%88%d9%85%d8%a4%d8%aa%d9%85%d8%b1%d8%a7%d8%aa/): الاحداث القادمة الاحداث السابقة Cath conference – 29/1/2025 – Fairmont Hotel .e… نشاط قادم لجمعيه اطباء القلب الاردنيه  نش… اعلان عن إقامه ورشه عمل في الايكو  اع… جمعية أطباء القلب الأردنية توقع اتفاقية تعاون مع دار النشر العالمية MD… نود في جمعيه اطباء القلب الاردنيه أن نتقدم بخالص الشكر والتقدير لجميع الزملاء الأطباء الذين شاركوا في مؤتمرنا الأخير AC… مع… لدعم الأطباء uptodate اتفاقية تعاون بين جمعية اطباء القلب الأردنية وموقع  لد… جمعية أطباء القلب الأردنية وجمعيه القلب الامريكيه  تتعاونان لتعزيز برامج الرعاية الصحية القلبيه وبرامج التثقيف الصحي العام حول القلب جم… المؤتمر الدولي الخامس عشر لجمعية أطباء القلب الاردنية […] - [تسجيل العضويات](https://jordan-cardiac.org/%d8%aa%d8%b3%d8%ac%d9%8a%d9%84-%d8%a7%d9%84%d8%b9%d8%b6%d9%88%d9%8a%d8%a7%d8%aa/) - [Approval membership application](https://jordan-cardiac.org/en/approval-membership-application/) - [موافقة طلب الانتساب](https://jordan-cardiac.org/%d9%85%d9%88%d8%a7%d9%81%d9%82%d8%a9-%d8%b7%d9%84%d8%a8-%d8%a7%d9%84%d8%a7%d9%86%d8%aa%d8%b3%d8%a7%d8%a8/) - [Types of memberships in the Society of Cardiologists](https://jordan-cardiac.org/en/types-of-memberships-in-the-society-of-cardiologists/): Founding member: He’s every doctor with a cardiologist’s degree, and he’s registered to the Society. EstablishmentHe has the right to stand as President and a member of the governing body of the Assembly.He has the right to vote in elections to the Assembly.He has the right to vote on decisions of the public body in administrative and financial matters.That is, if he meets the requirements under the union and association regulations. Working member:It’s every doctor who holds an adult cardiologist’s degree, or a cardiologist’s degree.Kiddos. Whit filed an application for association and is approved by the administrative body according toRegulations […] - [أنواع العضويات لجمعية أطباء القلب](https://jordan-cardiac.org/%d8%a3%d9%86%d9%88%d8%a7%d8%b9-%d8%a7%d9%84%d8%b9%d8%b6%d9%88%d9%8a%d8%a7%d8%aa-%d9%84%d8%ac%d9%85%d8%b9%d9%8a%d8%a9-%d8%a3%d8%b7%d8%a8%d8%a7%d8%a1-%d8%a7%d9%84%d9%82%d9%84%d8%a8/): العضو المؤسس:– هو كل طبيب يحمل شهادة الاختصاص في أمراض القلب، وكان مسجل بالجمعية عندإنشائها– وله حق الترشح لرئاسة وعضوية الهيئة الادارية للجمعية.– وله حق الانتخابات في انتخابات الجمعية.– وله الحق في التصويت على قرارات الهيئة العامة في الامور الادارية والمالية.وذلك إذا استوفى الشروط حسب أنظمة النقابة والجمعية العضو العامل:– هو كل طبيب ي حمل شهادة اختصاصي أمراض القلب للبالغين، أو اختصاص أمراض قلباألطفال. ويت قدم بطلب انتساب للجمعية ويتم الموافقة عليه من قبل الهيئة االدارية حسباألنظمة والتعليمات المعمول بها بالنقابة والجمعية– وله حق الترشح لرئاسة وعضوية الهيئة اإلدارية– وله حق االنتخاب في انتخابات الجمعية ،– وله الحق في التصويت […] - [About US](https://jordan-cardiac.org/en/about-us/): A Detailed Overview of the Jordanian Cardiac Society   The Jordanian Cardiac Society (JCS) stands as one of the most significant medical and non-profit health organizations in Jordan. It serves cardiologists within the kingdom and the Arab world, as well as the general public. The association encompasses various specialized working groups focusing on key cardiology fields, including interventional cardiology, heart failure, electrophysiology, valvular heart disease, hypertension, amyloidosis, and advanced cardiac imaging techniques like nuclear, magnetic, and echocardiography imaging Objectives of the Jordanian Heart Association Enhancing Physicians’ Skills JCS is committed to improving the skills of cardiologists by modernizing education and […] - [عن الجمعية](https://jordan-cardiac.org/%d8%b9%d9%86-%d8%a7%d9%84%d8%ac%d9%85%d8%b9%d9%8a%d8%a9/): نبذة عن جمعية أطباء القلب الأردنية  جمعية اطباء القلب الاردنيه هذه واحدة من أهم الجمعيات الطبيه والمنظمات الصحية الغير ربحية في الأردن ، تستهدف خدمة أطباء القلب بالمملكة والوطن العربي وكذلك الجمهور والمواطنين العرب ومن يطلب الخدمه .وفيها مجموعات عمل قائمه متفرعه من الجمعيه الام وتشمل التخصصات الرئيسيه في القلب مثل المجموعه التداخليه ، وهبوط القلب ، وكهربائيات القلب إضافه الى مراكز تعمل في طب صمامات القلب ، وارتفاع ضغط الدم والداء النشواني ( Amyloidosis) , وتصوير القلب النووي والمغناطيسي وفوق الصوتي حيث يوجد اطباء مختصون في كل منها.   أهداف جمعية اطباء القلب الاردنيه: تم إنشاء جمعية القلب الاردنيه […] - [نقاط الاعضاء](https://jordan-cardiac.org/en/%d9%86%d9%82%d8%a7%d8%b7-%d8%a7%d9%84%d8%a7%d8%b9%d8%b6%d8%a7%d8%a1/) - [نقاط الاعضاء](https://jordan-cardiac.org/%d9%86%d9%82%d8%a7%d8%b7-%d8%a7%d9%84%d8%a7%d8%b9%d8%b6%d8%a7%d8%a1/) - [Activity](https://jordan-cardiac.org/en/activity/): مواد تثقيفية اعتني بقلبك .elementor-3105… Read More April 13, 2024 - [نشاطات](https://jordan-cardiac.org/2820-2/): مواد تثقيفية اعتني بقلبك .elementor-3105… Read More April 13, 2024 - [Login](https://jordan-cardiac.org/login/) - [Account](https://jordan-cardiac.org/account/) - [Thank You](https://jordan-cardiac.org/thank-you/): Your subscription has been set up successfully. - [نقاطي](https://jordan-cardiac.org/%d9%86%d9%82%d8%a7%d8%b7%d9%8a/): [vc_row][vc_column offset=”vc_hidden-lg vc_hidden-md”][vc_empty_space height=”62px”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row] - [qr](https://jordan-cardiac.org/qr/) - [اثبات حضور](https://jordan-cardiac.org/en/%d8%a7%d8%ab%d8%a8%d8%a7%d8%aa-%d8%ad%d8%b6%d9%88%d8%b1/) - [اثبات حضور](https://jordan-cardiac.org/%d8%a7%d8%ab%d8%a8%d8%a7%d8%aa-%d8%ad%d8%b6%d9%88%d8%b1/) - [طلب انتساب جدول](https://jordan-cardiac.org/en/%d8%aa%d8%b3%d8%ac%d9%8a%d9%84-%d8%b9%d8%b6%d9%88%d9%8a%d8%a9-2/) - [طلب انتساب جدول](https://jordan-cardiac.org/%d8%aa%d8%b3%d8%ac%d9%8a%d9%84-%d8%b9%d8%b6%d9%88%d9%8a%d8%a9-2/) - [Membership registration](https://jordan-cardiac.org/en/membership-registration/): [vc_row][vc_column][/vc_column][/vc_row] - [تسجيل عضوية](https://jordan-cardiac.org/%d8%aa%d8%b3%d8%ac%d9%8a%d9%84-%d8%b9%d8%b6%d9%88%d9%8a%d8%a9/) - [My Bookings](https://jordan-cardiac.org/events/my-bookings/): CONTENTS - [Tags](https://jordan-cardiac.org/events/tags/): CONTENTS - [Categories](https://jordan-cardiac.org/events/categories/): CONTENTS - [Locations](https://jordan-cardiac.org/events/locations/): CONTENTS - [Events](https://jordan-cardiac.org/events/): CONTENTS - [Events Grid](https://jordan-cardiac.org/events-grid/): Upcoming Events The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllConferenceFestivalsMeetingWorkshop Conference November 5, 2019 Saturday at the Museum Series At City Center, 27 Division Street, USA Read More Meeting November 5, 2019 Cultural Counsil Grant Meeting At City Center, 27 Division Street, USA Read More Conference November 5, 2019 Smart City Council Meeting At City Center, 27 Division Street, USA Read More Festivals November 5, 2019 Sports Games for Children At City Center, 27 Division Street, USA Read More Workshop November 5, […] - [Shop](https://jordan-cardiac.org/shop/) - [My Account](https://jordan-cardiac.org/my-account/) - [Cart](https://jordan-cardiac.org/cart/) - [Checkout](https://jordan-cardiac.org/checkout/) - [Home 2](https://jordan-cardiac.org/home-2/): 0 350 Years of Foundation 0 215 k People in the city 0 15 k square of city 0 785 successful programs Meet Woman Who Care About Our City Mayor Christina J. Walsh, an accomplished advocate for working people and a proud product of the City, is the City’s 54th mayor. Mayor Walsh was sworn in to serve a second term on January 1, 2018. Learn more about Mayor Walsh and read his blog. Learn More It is more difficult to rule yourself than to rule a city. Trafic & Parking In the coming weeks, assessors will be performing inspections […] - [Coming Soon](https://jordan-cardiac.org/coming-soon/): Coming Soon *Your subscribe us to get noticed when our website is ready  - [Our History](https://jordan-cardiac.org/our-history/): Smart City History The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. 1902 Founding City We’ve been running data-driven voter outreach campaigns since 2004, including knocking on millions of doors to help elect President. 1928 Base Government We’ve been running data-driven voter outreach campaigns since 2004, including knocking on millions of doors to help elect President. 1956 Best Politics We’ve been running data-driven voter outreach campaigns since 2004, including knocking on millions of doors to help elect President. 2019 Smart City We’ve been running […] - [Services](https://jordan-cardiac.org/services/): We Provide Awesome City Services for You Mayor Christina J. Walsh, an accomplished advocate for working people and a proud product of the City, is the City’s 54th mayor. Mayor Walsh was sworn in to serve a second term Apply for a City job Building Permits & Licenses Find Affordable Housing Get a Resident Parking Permit Stay Connected Explore City Departments New applicant? Please search and apply online. If you’re a returning applicant, you can log in. We also have an employee search for current employees. View All Parking Clerk We collect and mediate disputes of fines and fees from […] - [Contact Us](https://jordan-cardiac.org/contact-us/): Call Us +1 800 123 456 789 Visit Us Here 27 Division St, New York, USA Open Hours Mon – Fri: 8.00 am. – 6.00 pm. Leave a Reply We are waiting for you on our office in New York or in way, contact us via the contact form below your idea. - [FAQ](https://jordan-cardiac.org/faq/): Together We Will Have Answers А сonsumers have the right to know what is in their drinking water air The information contained in an Annual Water Quality Report can raise south. awareness regarding the source of their Contact Us How can i pay for my order? Already the people had fled from the city by millions at first the rich, in their private motor-cars and dirigibles, and then the great mass of the population, on foot, carrying the plague What is theGov, and how does it work? Already the people had fled from the city by millions at first the […] - [اعضاء الهيئة الادارية](https://jordan-cardiac.org/member/): اعضاء الهيئة الادارية د. جمال الدباس رئيس الجمعية د. مصطفى الجمال نائب الرئيس د. علي الحلبي اللجنة العلمية د. حنا المخامرة ضابط ارتباط المجموعات د. عمار العوايشة مسؤول الموقع الالكتروني د. قيس البلبيسي اللجنة العلمية د.محمد الجعبري اللجنة الاجتماعية د.مهند عبابنه امين السر د.نائل الشوبكي امين الصندوق - [About Us](https://jordan-cardiac.org/about-us/): We Provide a Wide Range of Practice Area Mayor Christina J. Walsh, an accomplished advocate for working people and a proud product of the City, is the City’s 54th mayor. Mayor Walsh was sworn in to serve a second term on January 1, 2018. Learn more about Mayor Walsh and read his blog. Read More 0 350 Years of Foundation 0 215 k People in the city 0 15 k square of city 0 785 successful programs Meet City Council The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent […] - [Portfolio Gallery](https://jordan-cardiac.org/portfolio-gallery/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Load More - [Portfolio Masonry Style 4](https://jordan-cardiac.org/portfolio-masonry-style-4/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Building & Licenses Government Housing Authority Culture Parking Clerk Conference City Property Culture City job Business Affordable Housing Business Spring Conference Conference Resident Parking Permit Government Human Resources Business Load More - [Portfolio Masonry Style 3](https://jordan-cardiac.org/portfolio-masonry-style-3/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Tourism & Sport Culture City Recreation Government Economic Data Business Human Resources Business Resident Parking Permit Government Spring Conference Conference Affordable Housing Business City job Business Load More - [Portfolio Masonry Style 2](https://jordan-cardiac.org/portfolio-masonry-style-2/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Building & Licenses Government Housing Authority Culture Parking Clerk Conference City Property Culture City job Business Affordable Housing Business Spring Conference Conference Resident Parking Permit Government Load More - [Portfolio 5 Col Wide](https://jordan-cardiac.org/portfolio-5-col-wide/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Tourism & Sport Culture City Recreation Government Economic Data Business Human Resources Business Resident Parking Permit Government Spring Conference Conference Affordable Housing Business City job Business City Property Culture Parking Clerk Conference Load More - [Portfolio 4 Col Wide](https://jordan-cardiac.org/portfolio-4-col-wide/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Building & Licenses Government Housing Authority Culture Parking Clerk Conference City Property Culture City job Business Affordable Housing Business Spring Conference Conference Resident Parking Permit Government Load More - [Portfolio 2 Col](https://jordan-cardiac.org/portfolio-2-col/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Building & Licenses Government Housing Authority Culture Parking Clerk Conference City Property Culture City job Business Affordable Housing Business Load More - [Portfolio Grid](https://jordan-cardiac.org/portfolio-grid/): Meet City Projects The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. AllBusinessConferenceCultureGovernment Tourism & Sport Culture City Recreation Government Economic Data Business Human Resources Business Resident Parking Permit Government Spring Conference Conference Affordable Housing Business City job Business City Property Culture Load More - [4 Columns Full Width](https://jordan-cardiac.org/4-columns-full-width/): Read City News The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. Culture How to Make the Most of a Weekend developers November 4, 2019 Departments Exbition of the Picturesque City Views developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 The two halted, the nearer to us standing and facing Sunbury, a grey indistinctness towards the evening star. – James Doeh Trafic & Parking Change Your Place and Get the Fresh Air developers November 4, […] - [3 Columns](https://jordan-cardiac.org/3-columns/): Read City News The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. Culture How to Make the Most of a Weekend developers November 4, 2019 Departments Exbition of the Picturesque City Views developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 The two halted, the nearer to us standing and facing Sunbury, a grey indistinctness towards the evening star. – James Doeh Trafic & Parking Change Your Place and Get the Fresh Air developers November 4, […] - [2 Columns + Sidebar](https://jordan-cardiac.org/2-columns-sidebar/): Culture How to Make the Most of a Weekend developers November 4, 2019 Departments Exbition of the Picturesque City Views developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 The two halted, the nearer to us standing and facing Sunbury, a grey indistinctness towards the evening star. – James Doeh Trafic & Parking Change Your Place and Get the Fresh Air developers November 4, 2019 Culture 60 Anniversary of Museum of History developers November 4, 2019 Travel far enough, you meet yourself. Education Amazing Party Places to Visit at Day Time developers […] - [2 Columns](https://jordan-cardiac.org/2-columns/): Read City News The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. Culture How to Make the Most of a Weekend developers November 4, 2019 Departments Exbition of the Picturesque City Views developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 The two halted, the nearer to us standing and facing Sunbury, a grey indistinctness towards the evening star. – James Doeh Trafic & Parking Change Your Place and Get the Fresh Air developers November 4, […] - [Blog Masonry](https://jordan-cardiac.org/blog-masonry/): Read City News The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. Culture How to Make the Most of a Weekend developers November 4, 2019 Departments Exbition of the Picturesque City Views developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 The two halted, the nearer to us standing and facing Sunbury, a grey indistinctness towards the evening star. – James Doeh Trafic & Parking Change Your Place and Get the Fresh Air developers November 4, […] - [Blog Listing](https://jordan-cardiac.org/blog-listing/): Culture How to Make the Most of a Weekend The bodies were lying in the streets un-buried. All railroads and vessels carrying food and such things into the great city had ceased runnings and mobs of the hungry poor pillaging. Read More developers November 4, 2019 1 Departments Exbition of the Picturesque City Views The bodies were lying in the streets un-buried. All railroads and vessels carrying food and such things into the great city had ceased runnings and mobs of the hungry poor pillaging. Read More developers November 4, 2019 0 Education 14 Best Things to Do in Our […] - [Grid 4 Columns Full Width](https://jordan-cardiac.org/grid-4-columns-full-width/): Read City News The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. Culture How to Make the Most of a Weekend developers November 1, 2019 Departments New European Cultural Capital developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 Culture 60 Anniversary of Museum of History developers November 4, 2019 Trafic & Parking We Welcome Tourists and Guests developers November 4, 2019 Culture Informational City Portal is Open developers November 4, 2019 Departments Reliable Government for […] - [Grid 3 Columns](https://jordan-cardiac.org/grid-3-columns/): Read City News The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. Culture How to Make the Most of a Weekend developers November 1, 2019 Departments New European Cultural Capital developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 Culture 60 Anniversary of Museum of History developers November 4, 2019 Trafic & Parking We Welcome Tourists and Guests developers November 4, 2019 Culture Informational City Portal is Open developers November 4, 2019 Departments Reliable Government for […] - [Grid 2 Columns + Sidebar](https://jordan-cardiac.org/grid-2-columns-sidebar/): Culture How to Make the Most of a Weekend developers November 1, 2019 Departments New European Cultural Capital developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 Culture 60 Anniversary of Museum of History developers November 4, 2019 Trafic & Parking We Welcome Tourists and Guests developers November 4, 2019 Culture Informational City Portal is Open developers November 4, 2019 Departments Reliable Government for Happy CIitizens developers November 4, 2019 Trafic & Parking City Goverment is for Family Support developers November 4, 2019 Load More - [Grid 2 Columns](https://jordan-cardiac.org/grid-2-columns/): Read City News The council is made up of four at-large councilors that represent the entire City, and nine district councilors that represent specific areas of the City. Culture How to Make the Most of a Weekend developers November 1, 2019 Departments New European Cultural Capital developers November 4, 2019 Education 14 Best Things to Do in Our City developers November 4, 2019 Culture 60 Anniversary of Museum of History developers November 4, 2019 Trafic & Parking We Welcome Tourists and Guests developers November 4, 2019 Culture Informational City Portal is Open developers November 4, 2019 Load More - [مواد علمية](https://jordan-cardiac.org/%d9%85%d9%88%d8%a7%d8%af-%d8%b9%d9%84%d9%85%d9%8a%d8%a9/): مواد علمية تحتوي هذه الصفحة على مجموعه علمية طبية تثقيفية ومتنوعة  بروتوكولات طبيةمتنوعاتمواد تثقيفيةمواد علمية فهم تخْطِيطُ القلب April 14, 2024 - [Home](https://jordan-cardiac.org/en/): ADS Jordanian Cardiology Association 1 Working on developing doctors’ skills By updating the education and training system in sound practice and medical performance based on sound practice references in the field of medicine and cardiovascular diseases, as a specialized national reference that possesses the best human cadres and experts in various heart specialties. 2 Support scientific activities And expand its dissemination in all parts of the country by providing opportunities for continuing education and training for cardiologists in justice, to improve their skills and knowledge of the latest technologies and research, and their participation in research and in periodic conferences, […] - [Home](https://jordan-cardiac.org/home-1-2/): أعلانجمعية اطباء القلب الاردنية 1 العمل على تطوير مهارات الأطباء من خلال تحديث نظام التعليم والتدريب في الممارسه السليمه والأداء الطبي المستند إلى مرجعيات الممارسه السليمه فى مجال الطب وأمراض القلب والأوعية الدموية، باعتبارها مرجعاً وطنياً متخصصاً  يمتلك أفضل الكوادر البشرية والخبراء في تخصصات القلب المختلفه 2 دعم النشاطات العلميه والتوسع في نشرها في كافه ارجاء الوطن من خلال توفير فرص التعليم المستمر والتدريب لأطباء القلب بعداله،  لتحسين مهاراتهم ومعرفتهم بأحدث التقنيات والأبحاث، ومشاركاتهم  في الابحاث وفي المؤتمرات الدوريه وورش العمل واللقاءات العلميه الدوريه ، وتقديم الحالات الشهريه ودعم خاص لمشاركه الكفاءات الشابه 3 التفاعل مع الجامعات والهيئات الرسميه  من […] - [Elements](https://jordan-cardiac.org/elements/): Accordion & Tabs How can i pay for my order? Already the people had fled from the city by millions at first the rich, in their private motor-cars and dirigibles, and then the great mass of the population, on foot, carrying the plague What is theGov, and how does it work? Already the people had fled from the city by millions at first the rich, in their private motor-cars and dirigibles, and then the great mass of the population, on foot, carrying the plague Are there any discounts included? Already the people had fled from the city by millions at […] - [Typography](https://jordan-cardiac.org/typography/): Headings H1. Lorem Ipsum Dolor H2. Lorem Ipsum Dolor H3. Lorem Ipsum Dolor H4. Lorem Ipsum Dolor H5. Lorem Ipsum Dolor H6. Lorem Ipsum Dolor Text Elements The bodies were lying in the streets un-buried. All railroads and vessels carrying food and such things into the great city had ceased runnings and mobs of the hungry poor were pillaging the stores and warehouses. Murder and robbery and drunkenness were everywhere. Already the people had fled from the city by millions at first the rich, in their private motor-cars and dirigibles, and then the great mass of the population, on foot, […] - [My Bookings](https://jordan-cardiac.org/events-2/my-bookings/): CONTENTS - [Tags](https://jordan-cardiac.org/events-2/tags/): CONTENTS - [Categories](https://jordan-cardiac.org/events-2/categories/): CONTENTS - [Locations](https://jordan-cardiac.org/events-2/locations/): CONTENTS - [Events](https://jordan-cardiac.org/events-2/): CONTENTS - [سياسة الخصوصية(Privacy Policy)](https://jordan-cardiac.org/privacy-policy-2/): Privacy Policy Welcome to Jordan Cardiac Society! At Jordan Cardiac Society, we place the utmost importance on protecting your privacy and personal data. This policy explains how we collect, use, and protect your information to ensure a safe and transparent experience on our platform. By using the Jordan Cardiac Society platform, you agree to the practices outlined in this policy and comply with our terms and conditions. 1. Who We Are Our website address is: https://jordan-cardiac.org. 2. What Data We Collect and Why We Collect It Comments When visitors leave comments on the site, we collect the data shown in […] - [Sample Page](https://jordan-cardiac.org/sample-page/): This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger by day, aspiring actor by night, and this is my website. I live in Los Angeles, have a great dog named Jack, and I like piña coladas. (And gettin’ caught in the rain.) …or something like this: The XYZ Doohickey Company was founded in 1971, […] [comment]: # (Generated by Hostinger Tools Plugin)